[
  {
    "metadata": {
      "patient_id": "patient_0",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.109189"
    },
    "prediction": {
      "class": "Healthy",
      "probability": 0.3004406988620758,
      "confidence": 0.6995593309402466,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": -0.4297298491001129,
      "mean_abs_shap": 0.04072898550128395,
      "features_increasing_pd": 11,
      "features_decreasing_pd": 11
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "RPDE",
        "feature_value": 0.9643559392281215,
        "shap_value": -0.2135709971189499,
        "contribution": "decreases",
        "clinical_name": "Recurrence Period Density Entropy",
        "normal_range": "0.4-0.7",
        "pd_indication": "Altered RPDE reflects changes in vocal signal complexity"
      },
      {
        "rank": 2,
        "feature_name": "spread2",
        "feature_value": -1.1130128388448726,
        "shap_value": -0.15959645807743073,
        "contribution": "decreases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "D2",
        "feature_value": -0.8463968940548359,
        "shap_value": -0.09137323498725891,
        "contribution": "decreases",
        "clinical_name": "D2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 4,
        "feature_name": "DFA",
        "feature_value": -1.1553488063678083,
        "shap_value": 0.05151229351758957,
        "contribution": "increases",
        "clinical_name": "Detrended Fluctuation Analysis",
        "normal_range": "0.6-0.7",
        "pd_indication": "Abnormal DFA indicates disrupted vocal control dynamics"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:RAP",
        "feature_value": -0.6642930133376,
        "shap_value": -0.04838119447231293,
        "contribution": "decreases",
        "clinical_name": "MDVP:RAP",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -0.9190685222042366,
      "MDVP:Fhi(Hz)": -0.21712299794217949,
      "MDVP:Flo(Hz)": -0.4455603538856714,
      "MDVP:Jitter(%)": -0.6370267124068281,
      "MDVP:Jitter(Abs)": -0.4018994195636312,
      "MDVP:RAP": -0.6642930133376,
      "MDVP:PPQ": -0.5546577693830375,
      "Jitter:DDP": -0.6632462196414036,
      "MDVP:Shimmer": -0.7480189429945204,
      "MDVP:Shimmer(dB)": -0.7524105749055244,
      "Shimmer:APQ3": -0.8881277791750339,
      "Shimmer:APQ5": -0.6652518619148807,
      "MDVP:APQ": -0.42426733570857367,
      "Shimmer:DDA": -0.8881434961384941,
      "NHR": -0.4335164674659422,
      "HNR": 0.5239726392655514,
      "RPDE": 0.9643559392281215,
      "DFA": -1.1553488063678083,
      "spread1": 0.08443259466728534,
      "spread2": -1.1130128388448726,
      "D2": -0.8463968940548359,
      "PPE": 0.08671194470139681
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.020828593522310257,
      "MDVP:Fhi(Hz)": 0.011731374077498913,
      "MDVP:Flo(Hz)": 0.020357299596071243,
      "MDVP:Jitter(%)": 0.01267223246395588,
      "MDVP:Jitter(Abs)": 0.005127393174916506,
      "MDVP:RAP": -0.04838119447231293,
      "MDVP:PPQ": 0.01858794502913952,
      "Jitter:DDP": -0.02069689705967903,
      "MDVP:Shimmer": -0.02267793007194996,
      "MDVP:Shimmer(dB)": -0.03664661943912506,
      "Shimmer:APQ3": -0.004131636582314968,
      "Shimmer:APQ5": -0.0165976844727993,
      "MDVP:APQ": -0.011160476133227348,
      "Shimmer:DDA": 0.004973873030394316,
      "NHR": 0.005731936544179916,
      "HNR": -0.038050636649131775,
      "RPDE": -0.2135709971189499,
      "DFA": 0.05151229351758957,
      "spread1": 0.0427355095744133,
      "spread2": -0.15959645807743073,
      "D2": -0.09137323498725891,
      "PPE": 0.038895465433597565
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_0\nPREDICTION: Healthy\nCONFIDENCE: 70.0%\n\nTOP CONTRIBUTING FEATURES:\n\n1. Recurrence Period Density Entropy (RPDE)\n   Patient Value: 0.9644\n   Normal Range: 0.4-0.7\n   SHAP Impact: -0.2136 (\u2193 decreases PD probability)\n   Clinical Significance: Altered RPDE reflects changes in vocal signal complexity\n\n2. spread2 (spread2)\n   Patient Value: -1.1130\n   Normal Range: Not specified\n   SHAP Impact: -0.1596 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. D2 (D2)\n   Patient Value: -0.8464\n   Normal Range: Not specified\n   SHAP Impact: -0.0914 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n4. Detrended Fluctuation Analysis (DFA)\n   Patient Value: -1.1553\n   Normal Range: 0.6-0.7\n   SHAP Impact: 0.0515 (\u2191 increases PD probability)\n   Clinical Significance: Abnormal DFA indicates disrupted vocal control dynamics\n\n5. MDVP:RAP (MDVP:RAP)\n   Patient Value: -0.6643\n   Normal Range: Not specified\n   SHAP Impact: -0.0484 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_1",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.110010"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9941965341567993,
      "confidence": 0.9941965341567993,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2640260084881447,
      "mean_abs_shap": 0.020232239756627347,
      "features_increasing_pd": 12,
      "features_decreasing_pd": 10
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "PPE",
        "feature_value": 0.2913889891978622,
        "shap_value": 0.0903337299823761,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 2,
        "feature_name": "spread1",
        "feature_value": 0.2697860755980705,
        "shap_value": 0.08365587145090103,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "DFA",
        "feature_value": 1.7799285944680456,
        "shap_value": 0.07913791388273239,
        "contribution": "increases",
        "clinical_name": "Detrended Fluctuation Analysis",
        "normal_range": "0.6-0.7",
        "pd_indication": "Abnormal DFA indicates disrupted vocal control dynamics"
      },
      {
        "rank": 4,
        "feature_name": "spread2",
        "feature_value": 0.28923164753776676,
        "shap_value": 0.0407954603433609,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Fhi(Hz)",
        "feature_value": -0.7858157851722976,
        "shap_value": 0.038935523480176926,
        "contribution": "increases",
        "clinical_name": "Maximum Vocal Frequency",
        "normal_range": "102-592 Hz",
        "pd_indication": "Reduced range suggests limited vocal control"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -1.057573214231669,
      "MDVP:Fhi(Hz)": -0.7858157851722976,
      "MDVP:Flo(Hz)": -0.21892885554787295,
      "MDVP:Jitter(%)": -0.33096883030356256,
      "MDVP:Jitter(Abs)": -0.11398469945008191,
      "MDVP:RAP": -0.3534984727383944,
      "MDVP:PPQ": -0.23487792384436915,
      "Jitter:DDP": -0.35470454485915665,
      "MDVP:Shimmer": -0.4104059637991317,
      "MDVP:Shimmer(dB)": -0.4385873767393471,
      "Shimmer:APQ3": -0.27887108963627805,
      "Shimmer:APQ5": -0.4909811541428531,
      "MDVP:APQ": -0.45680550091748123,
      "Shimmer:DDA": -0.2788794985907688,
      "NHR": -0.5121478775075416,
      "HNR": 0.8911798302212182,
      "RPDE": -0.6660394065295782,
      "DFA": 1.7799285944680456,
      "spread1": 0.2697860755980705,
      "spread2": 0.28923164753776676,
      "D2": -1.5817165688969028,
      "PPE": 0.2913889891978622
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": -0.01918247900903225,
      "MDVP:Fhi(Hz)": 0.038935523480176926,
      "MDVP:Flo(Hz)": 0.00027612020494416356,
      "MDVP:Jitter(%)": -0.005071122199296951,
      "MDVP:Jitter(Abs)": -0.023444322869181633,
      "MDVP:RAP": 0.007232625503093004,
      "MDVP:PPQ": -0.007824552245438099,
      "Jitter:DDP": 0.005874992813915014,
      "MDVP:Shimmer": -0.00028992549050599337,
      "MDVP:Shimmer(dB)": 0.0015369142638519406,
      "Shimmer:APQ3": -0.0018032562220469117,
      "Shimmer:APQ5": -0.001343629788607359,
      "MDVP:APQ": 0.0026317331939935684,
      "Shimmer:DDA": 0.0011679749004542828,
      "NHR": 0.0029887815471738577,
      "HNR": -0.01159154437482357,
      "RPDE": -0.006555965170264244,
      "DFA": 0.07913791388273239,
      "spread1": 0.08365587145090103,
      "spread2": 0.0407954603433609,
      "D2": -0.013434835709631443,
      "PPE": 0.0903337299823761
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_1\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 99.4%\n\nTOP CONTRIBUTING FEATURES:\n\n1. Pitch Period Entropy (PPE)\n   Patient Value: 0.2914\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0903 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n2. spread1 (spread1)\n   Patient Value: 0.2698\n   Normal Range: Not specified\n   SHAP Impact: 0.0837 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Detrended Fluctuation Analysis (DFA)\n   Patient Value: 1.7799\n   Normal Range: 0.6-0.7\n   SHAP Impact: 0.0791 (\u2191 increases PD probability)\n   Clinical Significance: Abnormal DFA indicates disrupted vocal control dynamics\n\n4. spread2 (spread2)\n   Patient Value: 0.2892\n   Normal Range: Not specified\n   SHAP Impact: 0.0408 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n5. Maximum Vocal Frequency (MDVP:Fhi(Hz))\n   Patient Value: -0.7858\n   Normal Range: 102-592 Hz\n   SHAP Impact: 0.0389 (\u2191 increases PD probability)\n   Clinical Significance: Reduced range suggests limited vocal control\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_2",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.110724"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9999902248382568,
      "confidence": 0.9999902248382568,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.26981966057792306,
      "mean_abs_shap": 0.014945516151122072,
      "features_increasing_pd": 17,
      "features_decreasing_pd": 5
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": 1.3782474954037645,
        "shap_value": 0.07615558803081512,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "PPE",
        "feature_value": -0.14054877195116305,
        "shap_value": 0.03341841325163841,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 3,
        "feature_name": "spread1",
        "feature_value": -0.084208679625335,
        "shap_value": 0.03289525583386421,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 4,
        "feature_name": "DFA",
        "feature_value": 1.302284030781859,
        "shap_value": 0.0312492698431015,
        "contribution": "increases",
        "clinical_name": "Detrended Fluctuation Analysis",
        "normal_range": "0.6-0.7",
        "pd_indication": "Abnormal DFA indicates disrupted vocal control dynamics"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Shimmer(dB)",
        "feature_value": 0.3485429399725402,
        "shap_value": 0.018114250153303146,
        "contribution": "increases",
        "clinical_name": "Shimmer in Decibels",
        "normal_range": "<0.35 dB",
        "pd_indication": "Increased amplitude variation suggests vocal weakness"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -1.0016675078309494,
      "MDVP:Fhi(Hz)": -0.5290454633738098,
      "MDVP:Flo(Hz)": -0.2152430413850302,
      "MDVP:Jitter(%)": -0.2523864011148862,
      "MDVP:Jitter(Abs)": -0.11398469945008191,
      "MDVP:RAP": -0.20485760549529594,
      "MDVP:PPQ": -0.20217316691427797,
      "Jitter:DDP": -0.20493796549405136,
      "MDVP:Shimmer": 0.5466072055736239,
      "MDVP:Shimmer(dB)": 0.3485429399725402,
      "Shimmer:APQ3": 0.8359600327125956,
      "Shimmer:APQ5": 0.3695325799276376,
      "MDVP:APQ": 0.17502650713912163,
      "Shimmer:DDA": 0.8356358421421312,
      "NHR": -0.39184430063001563,
      "HNR": 0.33617821526663205,
      "RPDE": -0.08678612107227823,
      "DFA": 1.302284030781859,
      "spread1": -0.084208679625335,
      "spread2": 1.3782474954037645,
      "D2": -0.9792749476852431,
      "PPE": -0.14054877195116305
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.001887664315290749,
      "MDVP:Fhi(Hz)": 0.016536366194486618,
      "MDVP:Flo(Hz)": 0.0013472761493176222,
      "MDVP:Jitter(%)": -0.0037907096557319164,
      "MDVP:Jitter(Abs)": -0.01399213820695877,
      "MDVP:RAP": 0.009273039177060127,
      "MDVP:PPQ": -0.005702606402337551,
      "Jitter:DDP": 0.005458937492221594,
      "MDVP:Shimmer": 0.014779491350054741,
      "MDVP:Shimmer(dB)": 0.018114250153303146,
      "Shimmer:APQ3": 0.01507706381380558,
      "Shimmer:APQ5": 0.010322978720068932,
      "MDVP:APQ": 0.009867273271083832,
      "Shimmer:DDA": 0.011934003792703152,
      "NHR": 0.0003265732666477561,
      "HNR": 0.010667063295841217,
      "RPDE": -0.0038213045336306095,
      "DFA": 0.0312492698431015,
      "spread1": 0.03289525583386421,
      "spread2": 0.07615558803081512,
      "D2": -0.0021840885747224092,
      "PPE": 0.03341841325163841
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_2\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 100.0%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: 1.3782\n   Normal Range: Not specified\n   SHAP Impact: 0.0762 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. Pitch Period Entropy (PPE)\n   Patient Value: -0.1405\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0334 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n3. spread1 (spread1)\n   Patient Value: -0.0842\n   Normal Range: Not specified\n   SHAP Impact: 0.0329 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n4. Detrended Fluctuation Analysis (DFA)\n   Patient Value: 1.3023\n   Normal Range: 0.6-0.7\n   SHAP Impact: 0.0312 (\u2191 increases PD probability)\n   Clinical Significance: Abnormal DFA indicates disrupted vocal control dynamics\n\n5. Shimmer in Decibels (MDVP:Shimmer(dB))\n   Patient Value: 0.3485\n   Normal Range: <0.35 dB\n   SHAP Impact: 0.0181 (\u2191 increases PD probability)\n   Clinical Significance: Increased amplitude variation suggests vocal weakness\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_3",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.111224"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9912012815475464,
      "confidence": 0.9912012815475464,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2610307080321945,
      "mean_abs_shap": 0.016582844702167098,
      "features_increasing_pd": 13,
      "features_decreasing_pd": 9
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": 0.28575774023362516,
        "shap_value": 0.08244208246469498,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "D2",
        "feature_value": 0.2811952428065058,
        "shap_value": 0.07649334520101547,
        "contribution": "increases",
        "clinical_name": "D2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "spread1",
        "feature_value": -0.2562451812831731,
        "shap_value": 0.0467057079076767,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 4,
        "feature_name": "PPE",
        "feature_value": -0.3197830291466494,
        "shap_value": 0.03699660673737526,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Fo(Hz)",
        "feature_value": 1.3543413886447753,
        "shap_value": 0.020660623908042908,
        "contribution": "increases",
        "clinical_name": "Fundamental Frequency",
        "normal_range": "85-180 Hz (male), 165-255 Hz (female)",
        "pd_indication": "Reduced variability indicates vocal rigidity"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 1.3543413886447753,
      "MDVP:Fhi(Hz)": 0.3901204034944545,
      "MDVP:Flo(Hz)": 1.5879724287702721,
      "MDVP:Jitter(%)": -0.18207580657764952,
      "MDVP:Jitter(Abs)": -0.4018994195636312,
      "MDVP:RAP": -0.03256932755443189,
      "MDVP:PPQ": -0.23487792384436915,
      "Jitter:DDP": -0.031524031492350515,
      "MDVP:Shimmer": -0.6863447609682762,
      "MDVP:Shimmer(dB)": -0.6855302211979786,
      "Shimmer:APQ3": -0.696562466743075,
      "Shimmer:APQ5": -0.6427384211979202,
      "MDVP:APQ": -0.6549925071899174,
      "Shimmer:DDA": -0.69657588588848,
      "NHR": -0.4625381550838195,
      "HNR": 0.4043641279610523,
      "RPDE": -0.554025745424312,
      "DFA": 0.0752794111816711,
      "spread1": -0.2562451812831731,
      "spread2": 0.28575774023362516,
      "D2": 0.2811952428065058,
      "PPE": -0.3197830291466494
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.020660623908042908,
      "MDVP:Fhi(Hz)": -0.006809842772781849,
      "MDVP:Flo(Hz)": 0.009062165394425392,
      "MDVP:Jitter(%)": -0.011499527841806412,
      "MDVP:Jitter(Abs)": -0.008240560069680214,
      "MDVP:RAP": 0.004350499249994755,
      "MDVP:PPQ": -0.01532738283276558,
      "Jitter:DDP": -0.0026483836118131876,
      "MDVP:Shimmer": -0.0006365274894051254,
      "MDVP:Shimmer(dB)": -0.0029411932919174433,
      "Shimmer:APQ3": 0.0010272321524098516,
      "Shimmer:APQ5": -0.001509477966465056,
      "MDVP:APQ": -0.0022830418311059475,
      "Shimmer:DDA": 0.005419114138931036,
      "NHR": 0.0023867569398134947,
      "HNR": 0.014128067530691624,
      "RPDE": 0.0023877033963799477,
      "DFA": 0.010866740718483925,
      "spread1": 0.0467057079076767,
      "spread2": 0.08244208246469498,
      "D2": 0.07649334520101547,
      "PPE": 0.03699660673737526
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_3\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 99.1%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: 0.2858\n   Normal Range: Not specified\n   SHAP Impact: 0.0824 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. D2 (D2)\n   Patient Value: 0.2812\n   Normal Range: Not specified\n   SHAP Impact: 0.0765 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. spread1 (spread1)\n   Patient Value: -0.2562\n   Normal Range: Not specified\n   SHAP Impact: 0.0467 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n4. Pitch Period Entropy (PPE)\n   Patient Value: -0.3198\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0370 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n5. Fundamental Frequency (MDVP:Fo(Hz))\n   Patient Value: 1.3543\n   Normal Range: 85-180 Hz (male), 165-255 Hz (female)\n   SHAP Impact: 0.0207 (\u2191 increases PD probability)\n   Clinical Significance: Reduced variability indicates vocal rigidity\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_4",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.111684"
    },
    "prediction": {
      "class": "Healthy",
      "probability": 0.017773529514670372,
      "confidence": 0.9822264909744263,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": -0.7123970028478652,
      "mean_abs_shap": 0.059765984462997454,
      "features_increasing_pd": 7,
      "features_decreasing_pd": 15
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": -1.5702102932151414,
        "shap_value": -0.26472902297973633,
        "contribution": "decreases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "PPE",
        "feature_value": -1.1495160441308805,
        "shap_value": -0.14905835688114166,
        "contribution": "decreases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 3,
        "feature_name": "spread1",
        "feature_value": -1.1788798254334953,
        "shap_value": -0.1488867551088333,
        "contribution": "decreases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 4,
        "feature_name": "RPDE",
        "feature_value": -1.2893052930049893,
        "shap_value": 0.09815625101327896,
        "contribution": "increases",
        "clinical_name": "Recurrence Period Density Entropy",
        "normal_range": "0.4-0.7",
        "pd_indication": "Altered RPDE reflects changes in vocal signal complexity"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Fo(Hz)",
        "feature_value": 1.6473134505670894,
        "shap_value": -0.08969900757074356,
        "contribution": "decreases",
        "clinical_name": "Fundamental Frequency",
        "normal_range": "85-180 Hz (male), 165-255 Hz (female)",
        "pd_indication": "Reduced variability indicates vocal rigidity"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 1.6473134505670894,
      "MDVP:Fhi(Hz)": 0.3752064222735711,
      "MDVP:Flo(Hz)": 2.0541588113543368,
      "MDVP:Jitter(%)": -0.7362887282241034,
      "MDVP:Jitter(Abs)": -0.9777288597907295,
      "MDVP:RAP": -0.6034853858290599,
      "MDVP:PPQ": -0.7290831396768566,
      "Jitter:DDP": -0.6024387362901579,
      "MDVP:Shimmer": -0.7060166983387162,
      "MDVP:Shimmer(dB)": -0.7061087915695311,
      "Shimmer:APQ3": -0.6906377663585813,
      "Shimmer:APQ5": -0.5668597876703868,
      "MDVP:APQ": -0.7147444105735474,
      "Shimmer:DDA": -0.6903219604679468,
      "NHR": -0.5319917664770304,
      "HNR": 0.8993349559919798,
      "RPDE": -1.2893052930049893,
      "DFA": -0.4293971932062495,
      "spread1": -1.1788798254334953,
      "spread2": -1.5702102932151414,
      "D2": -0.27012754819409024,
      "PPE": -1.1495160441308805
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": -0.08969900757074356,
      "MDVP:Fhi(Hz)": -0.06674376875162125,
      "MDVP:Flo(Hz)": -0.028546489775180817,
      "MDVP:Jitter(%)": 0.030668845400214195,
      "MDVP:Jitter(Abs)": 0.08453952521085739,
      "MDVP:RAP": -0.03126852586865425,
      "MDVP:PPQ": 0.04350162670016289,
      "Jitter:DDP": -0.004178427625447512,
      "MDVP:Shimmer": -0.008239957503974438,
      "MDVP:Shimmer(dB)": -0.03155443072319031,
      "Shimmer:APQ3": 0.0012007637415081263,
      "Shimmer:APQ5": -0.00936538353562355,
      "MDVP:APQ": -0.046475447714328766,
      "Shimmer:DDA": 0.02305990271270275,
      "NHR": 0.020100412890315056,
      "HNR": -0.0865473523736,
      "RPDE": 0.09815625101327896,
      "DFA": -0.03280392289161682,
      "spread1": -0.1488867551088333,
      "spread2": -0.26472902297973633,
      "D2": -0.015527481213212013,
      "PPE": -0.14905835688114166
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_4\nPREDICTION: Healthy\nCONFIDENCE: 98.2%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: -1.5702\n   Normal Range: Not specified\n   SHAP Impact: -0.2647 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. Pitch Period Entropy (PPE)\n   Patient Value: -1.1495\n   Normal Range: 0.1-0.3\n   SHAP Impact: -0.1491 (\u2193 decreases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n3. spread1 (spread1)\n   Patient Value: -1.1789\n   Normal Range: Not specified\n   SHAP Impact: -0.1489 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n4. Recurrence Period Density Entropy (RPDE)\n   Patient Value: -1.2893\n   Normal Range: 0.4-0.7\n   SHAP Impact: 0.0982 (\u2191 increases PD probability)\n   Clinical Significance: Altered RPDE reflects changes in vocal signal complexity\n\n5. Fundamental Frequency (MDVP:Fo(Hz))\n   Patient Value: 1.6473\n   Normal Range: 85-180 Hz (male), 165-255 Hz (female)\n   SHAP Impact: -0.0897 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced variability indicates vocal rigidity\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_5",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.112149"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9999979734420776,
      "confidence": 0.9999979734420776,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2698274079230032,
      "mean_abs_shap": 0.016149893447039754,
      "features_increasing_pd": 14,
      "features_decreasing_pd": 8
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": 1.0745390457621393,
        "shap_value": 0.07796171307563782,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "D2",
        "feature_value": 1.8763735562864323,
        "shap_value": 0.07345813512802124,
        "contribution": "increases",
        "clinical_name": "D2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "HNR",
        "feature_value": -1.2934877512571619,
        "shap_value": 0.050260089337825775,
        "contribution": "increases",
        "clinical_name": "Harmonics-to-Noise Ratio",
        "normal_range": ">13 dB",
        "pd_indication": "Reduced HNR indicates increased vocal noise and hoarseness"
      },
      {
        "rank": 4,
        "feature_name": "PPE",
        "feature_value": -0.06818089639678192,
        "shap_value": 0.029514238238334656,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 5,
        "feature_name": "spread1",
        "feature_value": 0.02436778552340887,
        "shap_value": 0.028206966817378998,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 0.6479383922131552,
      "MDVP:Fhi(Hz)": 0.03309437692751471,
      "MDVP:Flo(Hz)": 0.902341885465952,
      "MDVP:Jitter(%)": -0.44677451542371704,
      "MDVP:Jitter(Abs)": -0.6898141396771803,
      "MDVP:RAP": -0.37376768190790777,
      "MDVP:PPQ": -0.3656969515647335,
      "Jitter:DDP": -0.3749737059762385,
      "MDVP:Shimmer": 0.4684511300748489,
      "MDVP:Shimmer(dB)": 0.2507947307076655,
      "Shimmer:APQ3": 0.5338003131034234,
      "Shimmer:APQ5": 0.5879963379959211,
      "MDVP:APQ": 0.27737382679623046,
      "Shimmer:DDA": 0.5338016521090334,
      "NHR": 0.07374294431661588,
      "HNR": -1.2934877512571619,
      "RPDE": 0.8202419195455439,
      "DFA": 0.17480152885903216,
      "spread1": 0.02436778552340887,
      "spread2": 1.0745390457621393,
      "D2": 1.8763735562864323,
      "PPE": -0.06818089639678192
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.011132905259728432,
      "MDVP:Fhi(Hz)": 0.004966219887137413,
      "MDVP:Flo(Hz)": -0.0013281414285302162,
      "MDVP:Jitter(%)": -0.0011633004760369658,
      "MDVP:Jitter(Abs)": 0.00579379266127944,
      "MDVP:RAP": 0.0008001654059626162,
      "MDVP:PPQ": -0.0041224416345357895,
      "Jitter:DDP": 0.00043355327215977013,
      "MDVP:Shimmer": 0.00257901125587523,
      "MDVP:Shimmer(dB)": 0.007140851579606533,
      "Shimmer:APQ3": -0.0007360044401139021,
      "Shimmer:APQ5": -0.00011490082397358492,
      "MDVP:APQ": 0.015240412205457687,
      "Shimmer:DDA": -0.016353221610188484,
      "NHR": -0.00476276408880949,
      "HNR": 0.050260089337825775,
      "RPDE": -0.014154349453747272,
      "DFA": 0.005074477754533291,
      "spread1": 0.028206966817378998,
      "spread2": 0.07796171307563782,
      "D2": 0.07345813512802124,
      "PPE": 0.029514238238334656
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_5\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 100.0%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: 1.0745\n   Normal Range: Not specified\n   SHAP Impact: 0.0780 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. D2 (D2)\n   Patient Value: 1.8764\n   Normal Range: Not specified\n   SHAP Impact: 0.0735 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Harmonics-to-Noise Ratio (HNR)\n   Patient Value: -1.2935\n   Normal Range: >13 dB\n   SHAP Impact: 0.0503 (\u2191 increases PD probability)\n   Clinical Significance: Reduced HNR indicates increased vocal noise and hoarseness\n\n4. Pitch Period Entropy (PPE)\n   Patient Value: -0.0682\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0295 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n5. spread1 (spread1)\n   Patient Value: 0.0244\n   Normal Range: Not specified\n   SHAP Impact: 0.0282 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_6",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.112626"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.8759065866470337,
      "confidence": 0.8759065866470337,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.14573602483142167,
      "mean_abs_shap": 0.018535376404708422,
      "features_increasing_pd": 15,
      "features_decreasing_pd": 7
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread1",
        "feature_value": -0.1909716593016484,
        "shap_value": 0.04286987707018852,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "RPDE",
        "feature_value": -0.06935662950100333,
        "shap_value": -0.040150176733732224,
        "contribution": "decreases",
        "clinical_name": "Recurrence Period Density Entropy",
        "normal_range": "0.4-0.7",
        "pd_indication": "Altered RPDE reflects changes in vocal signal complexity"
      },
      {
        "rank": 3,
        "feature_name": "MDVP:Jitter(Abs)",
        "feature_value": -0.6898141396771803,
        "shap_value": 0.03807618468999863,
        "contribution": "increases",
        "clinical_name": "Absolute Jitter",
        "normal_range": "<83 microseconds",
        "pd_indication": "Increased jitter reflects neuromuscular instability"
      },
      {
        "rank": 4,
        "feature_name": "PPE",
        "feature_value": -0.25564762521567175,
        "shap_value": 0.03332728147506714,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 5,
        "feature_name": "Shimmer:DDA",
        "feature_value": -1.0767487206629924,
        "shap_value": 0.0318351611495018,
        "contribution": "increases",
        "clinical_name": "Shimmer:DDA",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -0.8272165123812175,
      "MDVP:Fhi(Hz)": -0.772249650894962,
      "MDVP:Flo(Hz)": -0.2455127901973768,
      "MDVP:Jitter(%)": -0.7280168935726637,
      "MDVP:Jitter(Abs)": -0.6898141396771803,
      "MDVP:RAP": -0.7251006408461403,
      "MDVP:PPQ": -0.7617878966069476,
      "Jitter:DDP": -0.7240537029926494,
      "MDVP:Shimmer": -1.0361862417723169,
      "MDVP:Shimmer(dB)": -0.9890641341783796,
      "Shimmer:APQ3": -1.0767307414147458,
      "Shimmer:APQ5": -1.000451979256293,
      "MDVP:APQ": -0.8904505027016477,
      "Shimmer:DDA": -1.0767487206629924,
      "NHR": -0.4955286204955947,
      "HNR": 1.0155454982253274,
      "RPDE": -0.06935662950100333,
      "DFA": 0.013406476197477105,
      "spread1": -0.1909716593016484,
      "spread2": -0.3670363219324367,
      "D2": -0.7148807520808353,
      "PPE": -0.25564762521567175
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.0020559923723340034,
      "MDVP:Fhi(Hz)": 0.02884003147482872,
      "MDVP:Flo(Hz)": 0.01699690707027912,
      "MDVP:Jitter(%)": 0.014783957041800022,
      "MDVP:Jitter(Abs)": 0.03807618468999863,
      "MDVP:RAP": -0.015206793323159218,
      "MDVP:PPQ": 0.02737317979335785,
      "Jitter:DDP": -0.006076839752495289,
      "MDVP:Shimmer": 0.00406473595649004,
      "MDVP:Shimmer(dB)": -0.007838950492441654,
      "Shimmer:APQ3": 0.02287561446428299,
      "Shimmer:APQ5": 0.0015478272689506412,
      "MDVP:APQ": -0.014235683716833591,
      "Shimmer:DDA": 0.0318351611495018,
      "NHR": 0.0014511181507259607,
      "HNR": -0.022767653688788414,
      "RPDE": -0.040150176733732224,
      "DFA": 0.0019679730758070946,
      "spread1": 0.04286987707018852,
      "spread2": 0.008691311813890934,
      "D2": -0.0247450303286314,
      "PPE": 0.03332728147506714
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_6\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 87.6%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread1 (spread1)\n   Patient Value: -0.1910\n   Normal Range: Not specified\n   SHAP Impact: 0.0429 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. Recurrence Period Density Entropy (RPDE)\n   Patient Value: -0.0694\n   Normal Range: 0.4-0.7\n   SHAP Impact: -0.0402 (\u2193 decreases PD probability)\n   Clinical Significance: Altered RPDE reflects changes in vocal signal complexity\n\n3. Absolute Jitter (MDVP:Jitter(Abs))\n   Patient Value: -0.6898\n   Normal Range: <83 microseconds\n   SHAP Impact: 0.0381 (\u2191 increases PD probability)\n   Clinical Significance: Increased jitter reflects neuromuscular instability\n\n4. Pitch Period Entropy (PPE)\n   Patient Value: -0.2556\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0333 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n5. Shimmer:DDA (Shimmer:DDA)\n   Patient Value: -1.0767\n   Normal Range: Not specified\n   SHAP Impact: 0.0318 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_7",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.113108"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.914674699306488,
      "confidence": 0.914674699306488,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.18450409587239847,
      "mean_abs_shap": 0.012446488663871687,
      "features_increasing_pd": 14,
      "features_decreasing_pd": 8
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "MDVP:Fo(Hz)",
        "feature_value": -0.1317378979195819,
        "shap_value": 0.036669496446847916,
        "contribution": "increases",
        "clinical_name": "Fundamental Frequency",
        "normal_range": "85-180 Hz (male), 165-255 Hz (female)",
        "pd_indication": "Reduced variability indicates vocal rigidity"
      },
      {
        "rank": 2,
        "feature_name": "D2",
        "feature_value": -0.3411931460497619,
        "shap_value": 0.032496482133865356,
        "contribution": "increases",
        "clinical_name": "D2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "RPDE",
        "feature_value": -0.9254369255258675,
        "shap_value": 0.03222920373082161,
        "contribution": "increases",
        "clinical_name": "Recurrence Period Density Entropy",
        "normal_range": "0.4-0.7",
        "pd_indication": "Altered RPDE reflects changes in vocal signal complexity"
      },
      {
        "rank": 4,
        "feature_name": "MDVP:Jitter(Abs)",
        "feature_value": -0.6898141396771803,
        "shap_value": 0.030489996075630188,
        "contribution": "increases",
        "clinical_name": "Absolute Jitter",
        "normal_range": "<83 microseconds",
        "pd_indication": "Increased jitter reflects neuromuscular instability"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Fhi(Hz)",
        "feature_value": -0.4245818461962325,
        "shap_value": 0.02707308530807495,
        "contribution": "increases",
        "clinical_name": "Maximum Vocal Frequency",
        "normal_range": "102-592 Hz",
        "pd_indication": "Reduced range suggests limited vocal control"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -0.1317378979195819,
      "MDVP:Fhi(Hz)": -0.4245818461962325,
      "MDVP:Flo(Hz)": 0.5221271182301963,
      "MDVP:Jitter(%)": -0.6473665057211276,
      "MDVP:Jitter(Abs)": -0.6898141396771803,
      "MDVP:RAP": -0.6034853858290599,
      "MDVP:PPQ": -0.5764609406697648,
      "Jitter:DDP": -0.6035648007966624,
      "MDVP:Shimmer": -0.7427022031646718,
      "MDVP:Shimmer(dB)": -0.7215427193481956,
      "Shimmer:APQ3": -0.7182863681528847,
      "Shimmer:APQ5": -0.6936021205954978,
      "MDVP:APQ": -0.650259683159531,
      "Shimmer:DDA": -0.7179708939060931,
      "NHR": -0.49528057188347613,
      "HNR": 0.5722238000758884,
      "RPDE": -0.9254369255258675,
      "DFA": 0.8046009704360738,
      "spread1": -0.5771429070173618,
      "spread2": -0.5295166161541515,
      "D2": -0.3411931460497619,
      "PPE": -0.5144809830401509
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.036669496446847916,
      "MDVP:Fhi(Hz)": 0.02707308530807495,
      "MDVP:Flo(Hz)": -0.0019980783108621836,
      "MDVP:Jitter(%)": 0.011441400274634361,
      "MDVP:Jitter(Abs)": 0.030489996075630188,
      "MDVP:RAP": -0.0061338902451097965,
      "MDVP:PPQ": 0.006940985098481178,
      "Jitter:DDP": -0.002087215892970562,
      "MDVP:Shimmer": -0.00408950075507164,
      "MDVP:Shimmer(dB)": -0.00661084009334445,
      "Shimmer:APQ3": 0.0006810387712903321,
      "Shimmer:APQ5": -0.0019318017875775695,
      "MDVP:APQ": -0.006361810490489006,
      "Shimmer:DDA": 0.005613737273961306,
      "NHR": 0.002678629942238331,
      "HNR": 0.003239694284275174,
      "RPDE": 0.03222920373082161,
      "DFA": -0.015446189790964127,
      "spread1": 0.020971041172742844,
      "spread2": 0.002051034476608038,
      "D2": 0.032496482133865356,
      "PPE": 0.016587598249316216
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_7\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 91.5%\n\nTOP CONTRIBUTING FEATURES:\n\n1. Fundamental Frequency (MDVP:Fo(Hz))\n   Patient Value: -0.1317\n   Normal Range: 85-180 Hz (male), 165-255 Hz (female)\n   SHAP Impact: 0.0367 (\u2191 increases PD probability)\n   Clinical Significance: Reduced variability indicates vocal rigidity\n\n2. D2 (D2)\n   Patient Value: -0.3412\n   Normal Range: Not specified\n   SHAP Impact: 0.0325 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Recurrence Period Density Entropy (RPDE)\n   Patient Value: -0.9254\n   Normal Range: 0.4-0.7\n   SHAP Impact: 0.0322 (\u2191 increases PD probability)\n   Clinical Significance: Altered RPDE reflects changes in vocal signal complexity\n\n4. Absolute Jitter (MDVP:Jitter(Abs))\n   Patient Value: -0.6898\n   Normal Range: <83 microseconds\n   SHAP Impact: 0.0305 (\u2191 increases PD probability)\n   Clinical Significance: Increased jitter reflects neuromuscular instability\n\n5. Maximum Vocal Frequency (MDVP:Fhi(Hz))\n   Patient Value: -0.4246\n   Normal Range: 102-592 Hz\n   SHAP Impact: 0.0271 (\u2191 increases PD probability)\n   Clinical Significance: Reduced range suggests limited vocal control\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_8",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.113584"
    },
    "prediction": {
      "class": "Healthy",
      "probability": 0.009177332744002342,
      "confidence": 0.9908226728439331,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": -0.7209932663245127,
      "mean_abs_shap": 0.050765212831637735,
      "features_increasing_pd": 6,
      "features_decreasing_pd": 16
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": -0.8203271331406091,
        "shap_value": -0.16111911833286285,
        "contribution": "decreases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "PPE",
        "feature_value": -0.9918197126960832,
        "shap_value": -0.1349412202835083,
        "contribution": "decreases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 3,
        "feature_name": "spread1",
        "feature_value": -1.0199938523029093,
        "shap_value": -0.12546510994434357,
        "contribution": "decreases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 4,
        "feature_name": "MDVP:Fo(Hz)",
        "feature_value": 2.11161179557965,
        "shap_value": -0.10896177589893341,
        "contribution": "decreases",
        "clinical_name": "Fundamental Frequency",
        "normal_range": "85-180 Hz (male), 165-255 Hz (female)",
        "pd_indication": "Reduced variability indicates vocal rigidity"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Jitter(Abs)",
        "feature_value": -0.9777288597907295,
        "shap_value": 0.09639417380094528,
        "contribution": "increases",
        "clinical_name": "Absolute Jitter",
        "normal_range": "<83 microseconds",
        "pd_indication": "Increased jitter reflects neuromuscular instability"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 2.11161179557965,
      "MDVP:Fhi(Hz)": 0.5668527246777089,
      "MDVP:Flo(Hz)": 2.6758635152718515,
      "MDVP:Jitter(%)": -0.7052693482812049,
      "MDVP:Jitter(Abs)": -0.9777288597907295,
      "MDVP:RAP": -0.5865943781877987,
      "MDVP:PPQ": -0.6237011451243408,
      "Jitter:DDP": -0.5877998977055987,
      "MDVP:Shimmer": -0.643810842329487,
      "MDVP:Shimmer(dB)": -0.6598070082335378,
      "Shimmer:APQ3": -0.553382207451147,
      "Shimmer:APQ5": -0.625227967306951,
      "MDVP:APQ": -0.6845726573798333,
      "Shimmer:DDA": -0.5537230631247237,
      "NHR": -0.448895481417296,
      "HNR": 0.2852086791993738,
      "RPDE": -0.39386154645307864,
      "DFA": -1.5188681526409815,
      "spread1": -1.0199938523029093,
      "spread2": -0.8203271331406091,
      "D2": -0.32771545877308783,
      "PPE": -0.9918197126960832
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": -0.10896177589893341,
      "MDVP:Fhi(Hz)": -0.08994711935520172,
      "MDVP:Flo(Hz)": -0.022808192297816277,
      "MDVP:Jitter(%)": 0.025760017335414886,
      "MDVP:Jitter(Abs)": 0.09639417380094528,
      "MDVP:RAP": -0.028520967811346054,
      "MDVP:PPQ": 0.03585617616772652,
      "Jitter:DDP": -0.0001876492751762271,
      "MDVP:Shimmer": -0.010479291900992393,
      "MDVP:Shimmer(dB)": -0.034926995635032654,
      "Shimmer:APQ3": -0.009696072898805141,
      "Shimmer:APQ5": -0.012046796269714832,
      "MDVP:APQ": -0.047225967049598694,
      "Shimmer:DDA": 0.015617776662111282,
      "NHR": 0.016112178564071655,
      "HNR": -0.02893792651593685,
      "RPDE": 0.008180385455489159,
      "DFA": -0.07876637578010559,
      "spread1": -0.12546510994434357,
      "spread2": -0.16111911833286285,
      "D2": -0.024883395060896873,
      "PPE": -0.1349412202835083
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_8\nPREDICTION: Healthy\nCONFIDENCE: 99.1%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: -0.8203\n   Normal Range: Not specified\n   SHAP Impact: -0.1611 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. Pitch Period Entropy (PPE)\n   Patient Value: -0.9918\n   Normal Range: 0.1-0.3\n   SHAP Impact: -0.1349 (\u2193 decreases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n3. spread1 (spread1)\n   Patient Value: -1.0200\n   Normal Range: Not specified\n   SHAP Impact: -0.1255 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n4. Fundamental Frequency (MDVP:Fo(Hz))\n   Patient Value: 2.1116\n   Normal Range: 85-180 Hz (male), 165-255 Hz (female)\n   SHAP Impact: -0.1090 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced variability indicates vocal rigidity\n\n5. Absolute Jitter (MDVP:Jitter(Abs))\n   Patient Value: -0.9777\n   Normal Range: <83 microseconds\n   SHAP Impact: 0.0964 (\u2191 increases PD probability)\n   Clinical Significance: Increased jitter reflects neuromuscular instability\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_9",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.114582"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9994632601737976,
      "confidence": 0.9994632601737976,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2692927026655525,
      "mean_abs_shap": 0.01322776227871972,
      "features_increasing_pd": 15,
      "features_decreasing_pd": 7
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": 0.34232593322078186,
        "shap_value": 0.05798626318573952,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "D2",
        "feature_value": 0.3603720722004323,
        "shap_value": 0.05613122507929802,
        "contribution": "increases",
        "clinical_name": "D2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "DFA",
        "feature_value": -0.9469556883039105,
        "shap_value": 0.031045332551002502,
        "contribution": "increases",
        "clinical_name": "Detrended Fluctuation Analysis",
        "normal_range": "0.6-0.7",
        "pd_indication": "Abnormal DFA indicates disrupted vocal control dynamics"
      },
      {
        "rank": 4,
        "feature_name": "PPE",
        "feature_value": -0.07412162591961638,
        "shap_value": 0.03048603981733322,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 5,
        "feature_name": "spread1",
        "feature_value": 0.022236112437662103,
        "shap_value": 0.027286725118756294,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -0.3646864154480559,
      "MDVP:Fhi(Hz)": -0.1968724194732648,
      "MDVP:Flo(Hz)": -0.9161236407881123,
      "MDVP:Jitter(%)": -0.47986185402947557,
      "MDVP:Jitter(Abs)": -0.4018994195636312,
      "MDVP:RAP": -0.5595687659617807,
      "MDVP:PPQ": -0.49651597928509783,
      "Jitter:DDP": -0.5585222205364804,
      "MDVP:Shimmer": -0.706548372321701,
      "MDVP:Shimmer(dB)": -0.6598070082335378,
      "Shimmer:APQ3": -0.8278933252660158,
      "Shimmer:APQ5": -0.7136140678994627,
      "MDVP:APQ": -0.36155741730595214,
      "Shimmer:DDA": -0.8279083197196753,
      "NHR": -0.3581096893818846,
      "HNR": 0.6802792165384752,
      "RPDE": -0.6594611479509341,
      "DFA": -0.9469556883039105,
      "spread1": 0.022236112437662103,
      "spread2": 0.34232593322078186,
      "D2": 0.3603720722004323,
      "PPE": -0.07412162591961638
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.018717847764492035,
      "MDVP:Fhi(Hz)": 0.010981866158545017,
      "MDVP:Flo(Hz)": 0.020830126479268074,
      "MDVP:Jitter(%)": -0.0004718663403764367,
      "MDVP:Jitter(Abs)": -0.00683937082067132,
      "MDVP:RAP": -0.0006198645569384098,
      "MDVP:PPQ": -0.0009217170882038772,
      "Jitter:DDP": 0.001404864015057683,
      "MDVP:Shimmer": -0.00026452471502125263,
      "MDVP:Shimmer(dB)": -0.0008341073989868164,
      "Shimmer:APQ3": 0.004076628480106592,
      "Shimmer:APQ5": -0.0009075828129425645,
      "MDVP:APQ": 0.0039397431537508965,
      "Shimmer:DDA": 0.008151907473802567,
      "NHR": 0.0005613092216663063,
      "HNR": 0.0019765393808484077,
      "RPDE": 0.006575318519026041,
      "DFA": 0.031045332551002502,
      "spread1": 0.027286725118756294,
      "spread2": 0.05798626318573952,
      "D2": 0.05613122507929802,
      "PPE": 0.03048603981733322
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_9\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 99.9%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: 0.3423\n   Normal Range: Not specified\n   SHAP Impact: 0.0580 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. D2 (D2)\n   Patient Value: 0.3604\n   Normal Range: Not specified\n   SHAP Impact: 0.0561 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Detrended Fluctuation Analysis (DFA)\n   Patient Value: -0.9470\n   Normal Range: 0.6-0.7\n   SHAP Impact: 0.0310 (\u2191 increases PD probability)\n   Clinical Significance: Abnormal DFA indicates disrupted vocal control dynamics\n\n4. Pitch Period Entropy (PPE)\n   Patient Value: -0.0741\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0305 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n5. spread1 (spread1)\n   Patient Value: 0.0222\n   Normal Range: Not specified\n   SHAP Impact: 0.0273 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_10",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.115064"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 1.0,
      "confidence": 1.0,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.26982940250309184,
      "mean_abs_shap": 0.014626978438834405,
      "features_increasing_pd": 15,
      "features_decreasing_pd": 7
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "PPE",
        "feature_value": 1.8036050267239274,
        "shap_value": 0.05002114921808243,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 2,
        "feature_name": "spread1",
        "feature_value": 1.4798526494241746,
        "shap_value": 0.04057735949754715,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "spread2",
        "feature_value": 1.3111854578611923,
        "shap_value": 0.03027602657675743,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 4,
        "feature_name": "DFA",
        "feature_value": 1.8375619198515685,
        "shap_value": 0.02399110235273838,
        "contribution": "increases",
        "clinical_name": "Detrended Fluctuation Analysis",
        "normal_range": "0.6-0.7",
        "pd_indication": "Abnormal DFA indicates disrupted vocal control dynamics"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Shimmer",
        "feature_value": 1.6817311592463091,
        "shap_value": 0.021296773105859756,
        "contribution": "increases",
        "clinical_name": "Shimmer",
        "normal_range": "<3.81%",
        "pd_indication": "Elevated shimmer indicates amplitude perturbation and weak voice"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -0.7709716899104764,
      "MDVP:Fhi(Hz)": -0.5309740898946587,
      "MDVP:Flo(Hz)": -0.057720558600534516,
      "MDVP:Jitter(%)": 0.715418253103548,
      "MDVP:Jitter(Abs)": 1.037674181004115,
      "MDVP:RAP": 0.4538916925138899,
      "MDVP:PPQ": 1.2768086187020629,
      "Jitter:DDP": 0.45268370630460647,
      "MDVP:Shimmer": 1.6817311592463091,
      "MDVP:Shimmer(dB)": 1.7684642956096706,
      "Shimmer:APQ3": 1.5479115289159067,
      "Shimmer:APQ5": 2.2765043917679595,
      "MDVP:APQ": 1.1594539054595212,
      "Shimmer:DDA": 1.5482541861134036,
      "NHR": -0.13784252182055867,
      "HNR": -0.6345082827253689,
      "RPDE": -0.3875244263853819,
      "DFA": 1.8375619198515685,
      "spread1": 1.4798526494241746,
      "spread2": 1.3111854578611923,
      "D2": 0.2750771165961846,
      "PPE": 1.8036050267239274
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.004085595719516277,
      "MDVP:Fhi(Hz)": 0.009171964600682259,
      "MDVP:Flo(Hz)": -0.0003522850456647575,
      "MDVP:Jitter(%)": -0.0051507181487977505,
      "MDVP:Jitter(Abs)": -0.011269071139395237,
      "MDVP:RAP": 0.013345887884497643,
      "MDVP:PPQ": -0.006625364534556866,
      "Jitter:DDP": 0.007973280735313892,
      "MDVP:Shimmer": 0.021296773105859756,
      "MDVP:Shimmer(dB)": 0.021107511594891548,
      "Shimmer:APQ3": 0.01690409518778324,
      "Shimmer:APQ5": 0.018037639558315277,
      "MDVP:APQ": 0.009094641543924809,
      "Shimmer:DDA": 0.01176365464925766,
      "NHR": -0.0012588781537488103,
      "HNR": 0.018164781853556633,
      "RPDE": -0.0005997108528390527,
      "DFA": 0.02399110235273838,
      "spread1": 0.04057735949754715,
      "spread2": 0.03027602657675743,
      "D2": -0.0007260337006300688,
      "PPE": 0.05002114921808243
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_10\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 100.0%\n\nTOP CONTRIBUTING FEATURES:\n\n1. Pitch Period Entropy (PPE)\n   Patient Value: 1.8036\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0500 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n2. spread1 (spread1)\n   Patient Value: 1.4799\n   Normal Range: Not specified\n   SHAP Impact: 0.0406 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. spread2 (spread2)\n   Patient Value: 1.3112\n   Normal Range: Not specified\n   SHAP Impact: 0.0303 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n4. Detrended Fluctuation Analysis (DFA)\n   Patient Value: 1.8376\n   Normal Range: 0.6-0.7\n   SHAP Impact: 0.0240 (\u2191 increases PD probability)\n   Clinical Significance: Abnormal DFA indicates disrupted vocal control dynamics\n\n5. Shimmer (MDVP:Shimmer)\n   Patient Value: 1.6817\n   Normal Range: <3.81%\n   SHAP Impact: 0.0213 (\u2191 increases PD probability)\n   Clinical Significance: Elevated shimmer indicates amplitude perturbation and weak voice\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_11",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.115555"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9921501874923706,
      "confidence": 0.9921501874923706,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2619796423241496,
      "mean_abs_shap": 0.026656376113268463,
      "features_increasing_pd": 12,
      "features_decreasing_pd": 10
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread1",
        "feature_value": 0.7431067035195218,
        "shap_value": 0.11855990439653397,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "PPE",
        "feature_value": 0.6852126317228582,
        "shap_value": 0.10953166335821152,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 3,
        "feature_name": "MDVP:PPQ",
        "feature_value": 0.5100637617854832,
        "shap_value": -0.051040858030319214,
        "contribution": "decreases",
        "clinical_name": "MDVP:PPQ",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 4,
        "feature_name": "HNR",
        "feature_value": -0.13160886019509094,
        "shap_value": 0.042572323232889175,
        "contribution": "increases",
        "clinical_name": "Harmonics-to-Noise Ratio",
        "normal_range": ">13 dB",
        "pd_indication": "Reduced HNR indicates increased vocal noise and hoarseness"
      },
      {
        "rank": 5,
        "feature_name": "spread2",
        "feature_value": -0.17377167959340234,
        "shap_value": 0.03724796324968338,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 1.221674337537002,
      "MDVP:Fhi(Hz)": 0.2651322552171607,
      "MDVP:Flo(Hz)": 1.6884799737232925,
      "MDVP:Jitter(%)": 0.45278750292034065,
      "MDVP:Jitter(Abs)": -0.11398469945008191,
      "MDVP:RAP": 0.5788851490592228,
      "MDVP:PPQ": 0.5100637617854832,
      "Jitter:DDP": 0.5788029310331163,
      "MDVP:Shimmer": -0.315236320844841,
      "MDVP:Shimmer(dB)": -0.3717070230318012,
      "Shimmer:APQ3": -0.28578324008485395,
      "Shimmer:APQ5": -0.2541731110459352,
      "MDVP:APQ": -0.37930550741990154,
      "Shimmer:DDA": -0.2857917319503055,
      "NHR": -0.2898963210492668,
      "HNR": -0.13160886019509094,
      "RPDE": 0.003293581077216364,
      "DFA": 0.07221747091451813,
      "spread1": 0.7431067035195218,
      "spread2": -0.17377167959340234,
      "D2": -0.013297200404498088,
      "PPE": 0.6852126317228582
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.016947176307439804,
      "MDVP:Fhi(Hz)": -0.010934076271951199,
      "MDVP:Flo(Hz)": 0.018692990764975548,
      "MDVP:Jitter(%)": -0.026342786848545074,
      "MDVP:Jitter(Abs)": -0.026208048686385155,
      "MDVP:RAP": 0.024674663320183754,
      "MDVP:PPQ": -0.051040858030319214,
      "Jitter:DDP": 0.004179725423455238,
      "MDVP:Shimmer": -0.004298890940845013,
      "MDVP:Shimmer(dB)": 0.0021709431894123554,
      "Shimmer:APQ3": -0.006883305963128805,
      "Shimmer:APQ5": -0.0035919996444135904,
      "MDVP:APQ": 0.006596267223358154,
      "Shimmer:DDA": -0.008062257431447506,
      "NHR": -0.0020940143149346113,
      "HNR": 0.042572323232889175,
      "RPDE": -0.02277407795190811,
      "DFA": 0.015463698655366898,
      "spread1": 0.11855990439653397,
      "spread2": 0.03724796324968338,
      "D2": 0.027572639286518097,
      "PPE": 0.10953166335821152
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_11\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 99.2%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread1 (spread1)\n   Patient Value: 0.7431\n   Normal Range: Not specified\n   SHAP Impact: 0.1186 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. Pitch Period Entropy (PPE)\n   Patient Value: 0.6852\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.1095 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n3. MDVP:PPQ (MDVP:PPQ)\n   Patient Value: 0.5101\n   Normal Range: Not specified\n   SHAP Impact: -0.0510 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n4. Harmonics-to-Noise Ratio (HNR)\n   Patient Value: -0.1316\n   Normal Range: >13 dB\n   SHAP Impact: 0.0426 (\u2191 increases PD probability)\n   Clinical Significance: Reduced HNR indicates increased vocal noise and hoarseness\n\n5. spread2 (spread2)\n   Patient Value: -0.1738\n   Normal Range: Not specified\n   SHAP Impact: 0.0372 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_12",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.116037"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9933445453643799,
      "confidence": 0.9933445453643799,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2631738866912201,
      "mean_abs_shap": 0.03737055109707977,
      "features_increasing_pd": 13,
      "features_decreasing_pd": 9
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": 0.4211800228926352,
        "shap_value": 0.12663809955120087,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "MDVP:Fhi(Hz)",
        "feature_value": 3.241265971412745,
        "shap_value": -0.09947606921195984,
        "contribution": "decreases",
        "clinical_name": "Maximum Vocal Frequency",
        "normal_range": "102-592 Hz",
        "pd_indication": "Reduced range suggests limited vocal control"
      },
      {
        "rank": 3,
        "feature_name": "PPE",
        "feature_value": 0.7548882665571536,
        "shap_value": 0.08820094168186188,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 4,
        "feature_name": "D2",
        "feature_value": 0.8394847357417998,
        "shap_value": 0.08680456876754761,
        "contribution": "increases",
        "clinical_name": "D2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 5,
        "feature_name": "spread1",
        "feature_value": 0.9298763952147796,
        "shap_value": 0.08219723403453827,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -0.05708391736194827,
      "MDVP:Fhi(Hz)": 3.241265971412745,
      "MDVP:Flo(Hz)": -1.088228125854355,
      "MDVP:Jitter(%)": 0.48380688286323903,
      "MDVP:Jitter(Abs)": 0.4618447407770164,
      "MDVP:RAP": 0.2478213992905037,
      "MDVP:PPQ": 0.14667757367336015,
      "Jitter:DDP": 0.24661390161427363,
      "MDVP:Shimmer": -0.5996819017417434,
      "MDVP:Shimmer(dB)": -0.24309095820959736,
      "Shimmer:APQ3": -0.760746720908422,
      "Shimmer:APQ5": -0.7969971816659831,
      "MDVP:APQ": -0.6727405973038669,
      "Shimmer:DDA": -0.7604317559718179,
      "NHR": 0.8846138573323528,
      "HNR": 0.40934781593207353,
      "RPDE": -0.8761482138882281,
      "DFA": -1.0042991258514875,
      "spread1": 0.9298763952147796,
      "spread2": 0.4211800228926352,
      "D2": 0.8394847357417998,
      "PPE": 0.7548882665571536
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.03957783058285713,
      "MDVP:Fhi(Hz)": -0.09947606921195984,
      "MDVP:Flo(Hz)": 0.0517108328640461,
      "MDVP:Jitter(%)": -0.02378181740641594,
      "MDVP:Jitter(Abs)": -0.08140385895967484,
      "MDVP:RAP": 0.013714155182242393,
      "MDVP:PPQ": -0.04450467228889465,
      "Jitter:DDP": -0.01490006223320961,
      "MDVP:Shimmer": -0.0022927741520106792,
      "MDVP:Shimmer(dB)": 0.004091155715286732,
      "Shimmer:APQ3": 0.0037464553024619818,
      "Shimmer:APQ5": -0.0015928264474496245,
      "MDVP:APQ": -0.0022238122764974833,
      "Shimmer:DDA": 0.007292683701962233,
      "NHR": -0.009313225746154785,
      "HNR": 0.0018655890598893166,
      "RPDE": 0.015557907521724701,
      "DFA": 0.021265551447868347,
      "spread1": 0.08219723403453827,
      "spread2": 0.12663809955120087,
      "D2": 0.08680456876754761,
      "PPE": 0.08820094168186188
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_12\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 99.3%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: 0.4212\n   Normal Range: Not specified\n   SHAP Impact: 0.1266 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. Maximum Vocal Frequency (MDVP:Fhi(Hz))\n   Patient Value: 3.2413\n   Normal Range: 102-592 Hz\n   SHAP Impact: -0.0995 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced range suggests limited vocal control\n\n3. Pitch Period Entropy (PPE)\n   Patient Value: 0.7549\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0882 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n4. D2 (D2)\n   Patient Value: 0.8395\n   Normal Range: Not specified\n   SHAP Impact: 0.0868 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n5. spread1 (spread1)\n   Patient Value: 0.9299\n   Normal Range: Not specified\n   SHAP Impact: 0.0822 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_13",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.116483"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9910436868667603,
      "confidence": 0.9910436868667603,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.26087310424372845,
      "mean_abs_shap": 0.020064532747627793,
      "features_increasing_pd": 15,
      "features_decreasing_pd": 7
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "RPDE",
        "feature_value": -2.2655593773455776,
        "shap_value": 0.1120041087269783,
        "contribution": "increases",
        "clinical_name": "Recurrence Period Density Entropy",
        "normal_range": "0.4-0.7",
        "pd_indication": "Altered RPDE reflects changes in vocal signal complexity"
      },
      {
        "rank": 2,
        "feature_name": "MDVP:Fo(Hz)",
        "feature_value": -0.005465606989360974,
        "shap_value": 0.04385833442211151,
        "contribution": "increases",
        "clinical_name": "Fundamental Frequency",
        "normal_range": "85-180 Hz (male), 165-255 Hz (female)",
        "pd_indication": "Reduced variability indicates vocal rigidity"
      },
      {
        "rank": 3,
        "feature_name": "MDVP:Jitter(Abs)",
        "feature_value": -0.9777288597907295,
        "shap_value": 0.037150342017412186,
        "contribution": "increases",
        "clinical_name": "Absolute Jitter",
        "normal_range": "<83 microseconds",
        "pd_indication": "Increased jitter reflects neuromuscular instability"
      },
      {
        "rank": 4,
        "feature_name": "DFA",
        "feature_value": -0.4822292513069565,
        "shap_value": 0.02982616238296032,
        "contribution": "increases",
        "clinical_name": "Detrended Fluctuation Analysis",
        "normal_range": "0.6-0.7",
        "pd_indication": "Abnormal DFA indicates disrupted vocal control dynamics"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Fhi(Hz)",
        "feature_value": -0.40367378141339233,
        "shap_value": 0.028110258281230927,
        "contribution": "increases",
        "clinical_name": "Maximum Vocal Frequency",
        "normal_range": "102-592 Hz",
        "pd_indication": "Reduced range suggests limited vocal control"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -0.005465606989360974,
      "MDVP:Fhi(Hz)": -0.40367378141339233,
      "MDVP:Flo(Hz)": 0.2832633241394631,
      "MDVP:Jitter(%)": -0.9079292972414753,
      "MDVP:Jitter(Abs)": -0.9777288597907295,
      "MDVP:RAP": -0.8602287019762297,
      "MDVP:PPQ": -0.8889730624461907,
      "Jitter:DDP": -0.8591814437731955,
      "MDVP:Shimmer": -1.031932849908438,
      "MDVP:Shimmer(dB)": -0.9684855638068269,
      "Shimmer:APQ3": -1.0836428918633216,
      "Shimmer:APQ5": -1.0054549660822842,
      "MDVP:APQ": -0.9093817988231938,
      "Shimmer:DDA": -1.0839901079920309,
      "NHR": -0.5560524818525356,
      "HNR": 1.477669291901799,
      "RPDE": -2.2655593773455776,
      "DFA": -0.4822292513069565,
      "spread1": -1.3124588478968486,
      "spread2": -0.9824347937068624,
      "D2": -0.8285375179297593,
      "PPE": -1.2611105344746159
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.04385833442211151,
      "MDVP:Fhi(Hz)": 0.028110258281230927,
      "MDVP:Flo(Hz)": 0.006226458586752415,
      "MDVP:Jitter(%)": 0.012830512598156929,
      "MDVP:Jitter(Abs)": 0.037150342017412186,
      "MDVP:RAP": -0.005328415427356958,
      "MDVP:PPQ": 0.02217104285955429,
      "Jitter:DDP": 0.0019188174046576023,
      "MDVP:Shimmer": 0.010596427135169506,
      "MDVP:Shimmer(dB)": 2.0757057427545078e-05,
      "Shimmer:APQ3": 0.01746406964957714,
      "Shimmer:APQ5": 0.0037954244762659073,
      "MDVP:APQ": -0.00731945876032114,
      "Shimmer:DDA": 0.024276690557599068,
      "NHR": 0.0008970061899162829,
      "HNR": -0.015698911622166634,
      "RPDE": 0.1120041087269783,
      "DFA": 0.02982616238296032,
      "spread1": -0.014321166090667248,
      "spread2": -0.014492666348814964,
      "D2": -0.013172771781682968,
      "PPE": -0.01993991807103157
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_13\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 99.1%\n\nTOP CONTRIBUTING FEATURES:\n\n1. Recurrence Period Density Entropy (RPDE)\n   Patient Value: -2.2656\n   Normal Range: 0.4-0.7\n   SHAP Impact: 0.1120 (\u2191 increases PD probability)\n   Clinical Significance: Altered RPDE reflects changes in vocal signal complexity\n\n2. Fundamental Frequency (MDVP:Fo(Hz))\n   Patient Value: -0.0055\n   Normal Range: 85-180 Hz (male), 165-255 Hz (female)\n   SHAP Impact: 0.0439 (\u2191 increases PD probability)\n   Clinical Significance: Reduced variability indicates vocal rigidity\n\n3. Absolute Jitter (MDVP:Jitter(Abs))\n   Patient Value: -0.9777\n   Normal Range: <83 microseconds\n   SHAP Impact: 0.0372 (\u2191 increases PD probability)\n   Clinical Significance: Increased jitter reflects neuromuscular instability\n\n4. Detrended Fluctuation Analysis (DFA)\n   Patient Value: -0.4822\n   Normal Range: 0.6-0.7\n   SHAP Impact: 0.0298 (\u2191 increases PD probability)\n   Clinical Significance: Abnormal DFA indicates disrupted vocal control dynamics\n\n5. Maximum Vocal Frequency (MDVP:Fhi(Hz))\n   Patient Value: -0.4037\n   Normal Range: 102-592 Hz\n   SHAP Impact: 0.0281 (\u2191 increases PD probability)\n   Clinical Significance: Reduced range suggests limited vocal control\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_14",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.116927"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9977403879165649,
      "confidence": 0.9977403879165649,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.267569818359334,
      "mean_abs_shap": 0.0144554325141309,
      "features_increasing_pd": 17,
      "features_decreasing_pd": 5
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "D2",
        "feature_value": 0.3072732319658232,
        "shap_value": 0.07443888485431671,
        "contribution": "increases",
        "clinical_name": "D2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "spread2",
        "feature_value": 0.2724030308395051,
        "shap_value": 0.05739733204245567,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "RPDE",
        "feature_value": -1.0125168645991764,
        "shap_value": 0.027725741267204285,
        "contribution": "increases",
        "clinical_name": "Recurrence Period Density Entropy",
        "normal_range": "0.4-0.7",
        "pd_indication": "Altered RPDE reflects changes in vocal signal complexity"
      },
      {
        "rank": 4,
        "feature_name": "MDVP:Fo(Hz)",
        "feature_value": -0.0567932464447875,
        "shap_value": 0.02586408331990242,
        "contribution": "increases",
        "clinical_name": "Fundamental Frequency",
        "normal_range": "85-180 Hz (male), 165-255 Hz (female)",
        "pd_indication": "Reduced variability indicates vocal rigidity"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Fhi(Hz)",
        "feature_value": -0.4310909607040982,
        "shap_value": 0.0182572640478611,
        "contribution": "increases",
        "clinical_name": "Maximum Vocal Frequency",
        "normal_range": "102-592 Hz",
        "pd_indication": "Reduced range suggests limited vocal control"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -0.0567932464447875,
      "MDVP:Fhi(Hz)": -0.4310909607040982,
      "MDVP:Flo(Hz)": 0.40143974073561123,
      "MDVP:Jitter(%)": -0.7528323975269826,
      "MDVP:Jitter(Abs)": -0.6898141396771803,
      "MDVP:RAP": -0.7284788423743925,
      "MDVP:PPQ": -0.8090281010615236,
      "Jitter:DDP": -0.7274318965121631,
      "MDVP:Shimmer": -0.808629777054795,
      "MDVP:Shimmer(dB)": -0.7472659323126363,
      "Shimmer:APQ3": -0.9217010813538308,
      "Shimmer:APQ5": -0.8336857517232521,
      "MDVP:APQ": -0.6751070093190602,
      "Shimmer:DDA": -0.9220463549971735,
      "NHR": -0.4528642592111937,
      "HNR": 1.1206560081595833,
      "RPDE": -1.0125168645991764,
      "DFA": -0.3234613071586387,
      "spread1": -0.842025818547115,
      "spread2": 0.2724030308395051,
      "D2": 0.3072732319658232,
      "PPE": -1.126353873968817
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.02586408331990242,
      "MDVP:Fhi(Hz)": 0.0182572640478611,
      "MDVP:Flo(Hz)": 0.001918945461511612,
      "MDVP:Jitter(%)": 0.006697774399071932,
      "MDVP:Jitter(Abs)": 0.01413898915052414,
      "MDVP:RAP": -0.002333400072529912,
      "MDVP:PPQ": 0.0142202852293849,
      "Jitter:DDP": 0.00232901144772768,
      "MDVP:Shimmer": 0.0020415710750967264,
      "MDVP:Shimmer(dB)": -0.0007976387278176844,
      "Shimmer:APQ3": 0.007422714028507471,
      "Shimmer:APQ5": 0.0005705456715077162,
      "MDVP:APQ": -0.001596301794052124,
      "Shimmer:DDA": 0.015217971056699753,
      "NHR": 0.0012395732337608933,
      "HNR": -0.006778157781809568,
      "RPDE": 0.027725741267204285,
      "DFA": 0.0165563877671957,
      "spread1": 0.006757592782378197,
      "spread2": 0.05739733204245567,
      "D2": 0.07443888485431671,
      "PPE": -0.013719350099563599
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_14\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 99.8%\n\nTOP CONTRIBUTING FEATURES:\n\n1. D2 (D2)\n   Patient Value: 0.3073\n   Normal Range: Not specified\n   SHAP Impact: 0.0744 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. spread2 (spread2)\n   Patient Value: 0.2724\n   Normal Range: Not specified\n   SHAP Impact: 0.0574 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Recurrence Period Density Entropy (RPDE)\n   Patient Value: -1.0125\n   Normal Range: 0.4-0.7\n   SHAP Impact: 0.0277 (\u2191 increases PD probability)\n   Clinical Significance: Altered RPDE reflects changes in vocal signal complexity\n\n4. Fundamental Frequency (MDVP:Fo(Hz))\n   Patient Value: -0.0568\n   Normal Range: 85-180 Hz (male), 165-255 Hz (female)\n   SHAP Impact: 0.0259 (\u2191 increases PD probability)\n   Clinical Significance: Reduced variability indicates vocal rigidity\n\n5. Maximum Vocal Frequency (MDVP:Fhi(Hz))\n   Patient Value: -0.4311\n   Normal Range: 102-592 Hz\n   SHAP Impact: 0.0183 (\u2191 increases PD probability)\n   Clinical Significance: Reduced range suggests limited vocal control\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_15",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.117350"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 1.0,
      "confidence": 1.0,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2698293983703479,
      "mean_abs_shap": 0.016818476041821254,
      "features_increasing_pd": 16,
      "features_decreasing_pd": 6
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "PPE",
        "feature_value": 1.4915387273886545,
        "shap_value": 0.057153649628162384,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 2,
        "feature_name": "spread1",
        "feature_value": 1.530569547905149,
        "shap_value": 0.046734265983104706,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "HNR",
        "feature_value": -1.483320956698771,
        "shap_value": 0.040737252682447433,
        "contribution": "increases",
        "clinical_name": "Harmonics-to-Noise Ratio",
        "normal_range": ">13 dB",
        "pd_indication": "Reduced HNR indicates increased vocal noise and hoarseness"
      },
      {
        "rank": 4,
        "feature_name": "MDVP:RAP",
        "feature_value": 1.3930317173680116,
        "shap_value": 0.035118069499731064,
        "contribution": "increases",
        "clinical_name": "MDVP:RAP",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 5,
        "feature_name": "spread2",
        "feature_value": 0.46644900181095916,
        "shap_value": 0.025990376248955727,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -0.7071209784406773,
      "MDVP:Fhi(Hz)": -0.5825210169064412,
      "MDVP:Flo(Hz)": -0.00317050899046073,
      "MDVP:Jitter(%)": 1.3606213559158378,
      "MDVP:Jitter(Abs)": 1.6135036212312133,
      "MDVP:RAP": 1.3930317173680116,
      "MDVP:PPQ": 1.0115367013802132,
      "Jitter:DDP": 1.3918215047294025,
      "MDVP:Shimmer": 0.48652804549633427,
      "MDVP:Shimmer(dB)": 0.3073857992294352,
      "Shimmer:APQ3": 0.561448914897727,
      "Shimmer:APQ5": 0.32200420508072086,
      "MDVP:APQ": 0.4022020605976754,
      "Shimmer:DDA": 0.5617797395166816,
      "NHR": 1.4055159427814345,
      "HNR": -1.483320956698771,
      "RPDE": 1.2639367796886778,
      "DFA": -0.06547925115865262,
      "spread1": 1.530569547905149,
      "spread2": 0.46644900181095916,
      "D2": 0.7595248071454402,
      "PPE": 1.4915387273886545
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.013429087586700916,
      "MDVP:Fhi(Hz)": 0.01650567166507244,
      "MDVP:Flo(Hz)": -0.0014536719536408782,
      "MDVP:Jitter(%)": -0.007856580428779125,
      "MDVP:Jitter(Abs)": -0.016227535903453827,
      "MDVP:RAP": 0.035118069499731064,
      "MDVP:PPQ": -0.007180282846093178,
      "Jitter:DDP": 0.020328642800450325,
      "MDVP:Shimmer": 0.009901085868477821,
      "MDVP:Shimmer(dB)": 0.009242769330739975,
      "Shimmer:APQ3": 0.005951217375695705,
      "Shimmer:APQ5": 0.006604789290577173,
      "MDVP:APQ": 0.00779053196310997,
      "Shimmer:DDA": 0.006110455375164747,
      "NHR": -0.012226976454257965,
      "HNR": 0.040737252682447433,
      "RPDE": 0.015179594978690147,
      "DFA": 0.003140475368127227,
      "spread1": 0.046734265983104706,
      "spread2": 0.025990376248955727,
      "D2": -0.0051434896886348724,
      "PPE": 0.057153649628162384
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_15\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 100.0%\n\nTOP CONTRIBUTING FEATURES:\n\n1. Pitch Period Entropy (PPE)\n   Patient Value: 1.4915\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0572 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n2. spread1 (spread1)\n   Patient Value: 1.5306\n   Normal Range: Not specified\n   SHAP Impact: 0.0467 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Harmonics-to-Noise Ratio (HNR)\n   Patient Value: -1.4833\n   Normal Range: >13 dB\n   SHAP Impact: 0.0407 (\u2191 increases PD probability)\n   Clinical Significance: Reduced HNR indicates increased vocal noise and hoarseness\n\n4. MDVP:RAP (MDVP:RAP)\n   Patient Value: 1.3930\n   Normal Range: Not specified\n   SHAP Impact: 0.0351 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n5. spread2 (spread2)\n   Patient Value: 0.4664\n   Normal Range: Not specified\n   SHAP Impact: 0.0260 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_16",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.117774"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 1.0,
      "confidence": 1.0,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.26982944103656337,
      "mean_abs_shap": 0.01743555243328129,
      "features_increasing_pd": 17,
      "features_decreasing_pd": 5
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": 2.046307517003249,
        "shap_value": 0.07984069734811783,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "spread1",
        "feature_value": 2.5335621979133958,
        "shap_value": 0.07342275232076645,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "PPE",
        "feature_value": 1.787573956981596,
        "shap_value": 0.07209006696939468,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 4,
        "feature_name": "MDVP:Jitter(Abs)",
        "feature_value": 1.325588901117664,
        "shap_value": -0.031271450221538544,
        "contribution": "decreases",
        "clinical_name": "Absolute Jitter",
        "normal_range": "<83 microseconds",
        "pd_indication": "Increased jitter reflects neuromuscular instability"
      },
      {
        "rank": 5,
        "feature_name": "HNR",
        "feature_value": -0.7790352338849716,
        "shap_value": 0.023900169879198074,
        "contribution": "increases",
        "clinical_name": "Harmonics-to-Noise Ratio",
        "normal_range": ">13 dB",
        "pd_indication": "Reduced HNR indicates increased vocal noise and hoarseness"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -1.258499485719523,
      "MDVP:Fhi(Hz)": -0.5947502623454609,
      "MDVP:Flo(Hz)": -0.7008260210010553,
      "MDVP:Jitter(%)": 0.589272774669094,
      "MDVP:Jitter(Abs)": 1.325588901117664,
      "MDVP:RAP": 0.5484813353049528,
      "MDVP:PPQ": 0.4228510766385738,
      "Jitter:DDP": 0.5495252538639981,
      "MDVP:Shimmer": -0.08342646426344023,
      "MDVP:Shimmer(dB)": -0.05273918227273554,
      "Shimmer:APQ3": 0.012426679267989045,
      "Shimmer:APQ5": -0.19580493140937083,
      "MDVP:APQ": -0.19827498825761666,
      "Shimmer:DDA": 0.01209261044877152,
      "NHR": 0.34659641764708715,
      "HNR": -0.7790352338849716,
      "RPDE": 1.6671589521544086,
      "DFA": -0.7888037558069744,
      "spread1": 2.5335621979133958,
      "spread2": 2.046307517003249,
      "D2": 0.4677535681863728,
      "PPE": 1.787573956981596
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.0037543626967817545,
      "MDVP:Fhi(Hz)": 0.012234549969434738,
      "MDVP:Flo(Hz)": 0.005704029928892851,
      "MDVP:Jitter(%)": -0.006132867187261581,
      "MDVP:Jitter(Abs)": -0.031271450221538544,
      "MDVP:RAP": 0.01845099776983261,
      "MDVP:PPQ": -0.008363696746528149,
      "Jitter:DDP": 0.009873660281300545,
      "MDVP:Shimmer": 0.004648419097065926,
      "MDVP:Shimmer(dB)": 0.0052855126559734344,
      "Shimmer:APQ3": 0.0024821367114782333,
      "Shimmer:APQ5": 0.00212881900370121,
      "MDVP:APQ": 0.0027472248766571283,
      "Shimmer:DDA": 0.0008103823638521135,
      "NHR": -0.005040570627897978,
      "HNR": 0.023900169879198074,
      "RPDE": 0.003452162491157651,
      "DFA": -0.006067771464586258,
      "spread1": 0.07342275232076645,
      "spread2": 0.07984069734811783,
      "D2": 0.005879852920770645,
      "PPE": 0.07209006696939468
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_16\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 100.0%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: 2.0463\n   Normal Range: Not specified\n   SHAP Impact: 0.0798 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. spread1 (spread1)\n   Patient Value: 2.5336\n   Normal Range: Not specified\n   SHAP Impact: 0.0734 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Pitch Period Entropy (PPE)\n   Patient Value: 1.7876\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0721 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n4. Absolute Jitter (MDVP:Jitter(Abs))\n   Patient Value: 1.3256\n   Normal Range: <83 microseconds\n   SHAP Impact: -0.0313 (\u2193 decreases PD probability)\n   Clinical Significance: Increased jitter reflects neuromuscular instability\n\n5. Harmonics-to-Noise Ratio (HNR)\n   Patient Value: -0.7790\n   Normal Range: >13 dB\n   SHAP Impact: 0.0239 (\u2191 increases PD probability)\n   Clinical Significance: Reduced HNR indicates increased vocal noise and hoarseness\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_17",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.119612"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 1.0,
      "confidence": 1.0,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2698293830908369,
      "mean_abs_shap": 0.016314715989706616,
      "features_increasing_pd": 14,
      "features_decreasing_pd": 8
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": 2.498035670946583,
        "shap_value": 0.10545971244573593,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "PPE",
        "feature_value": 2.4946208948538033,
        "shap_value": 0.071247898042202,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 3,
        "feature_name": "spread1",
        "feature_value": 2.5320071249246134,
        "shap_value": 0.059926919639110565,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 4,
        "feature_name": "D2",
        "feature_value": 1.6385811620168829,
        "shap_value": 0.03051827847957611,
        "contribution": "increases",
        "clinical_name": "D2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 5,
        "feature_name": "RPDE",
        "feature_value": 1.2786462288564664,
        "shap_value": -0.010874859057366848,
        "contribution": "decreases",
        "clinical_name": "Recurrence Period Density Entropy",
        "normal_range": "0.4-0.7",
        "pd_indication": "Altered RPDE reflects changes in vocal signal complexity"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 0.35242295976567783,
      "MDVP:Fhi(Hz)": 0.384367398247604,
      "MDVP:Flo(Hz)": -0.938077271395545,
      "MDVP:Jitter(%)": 0.19842858738857244,
      "MDVP:Jitter(Abs)": -0.11398469945008191,
      "MDVP:RAP": -0.15756278409976465,
      "MDVP:PPQ": 0.15394529743560262,
      "Jitter:DDP": -0.15651719171435569,
      "MDVP:Shimmer": 0.18932228900779527,
      "MDVP:Shimmer(dB)": 0.3382536547867639,
      "Shimmer:APQ3": -0.12384142957536304,
      "Shimmer:APQ5": 0.08769765539679848,
      "MDVP:APQ": 0.6045302878966996,
      "Shimmer:DDA": -0.12417713292494978,
      "NHR": 0.10772560417686547,
      "HNR": -0.3420564113350133,
      "RPDE": 1.2786462288564664,
      "DFA": -2.0415721568266414,
      "spread1": 2.5320071249246134,
      "spread2": 2.498035670946583,
      "D2": 1.6385811620168829,
      "PPE": 2.4946208948538033
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.0050642043352127075,
      "MDVP:Fhi(Hz)": -0.0017030173912644386,
      "MDVP:Flo(Hz)": 0.007298561278730631,
      "MDVP:Jitter(%)": -0.00498053478077054,
      "MDVP:Jitter(Abs)": -0.010516461916267872,
      "MDVP:RAP": 0.0023822530638426542,
      "MDVP:PPQ": -0.009484187699854374,
      "Jitter:DDP": 0.00022375554544851184,
      "MDVP:Shimmer": 0.0034343034494668245,
      "MDVP:Shimmer(dB)": 0.005024929530918598,
      "Shimmer:APQ3": -0.00027263021911494434,
      "Shimmer:APQ5": 0.002193138236179948,
      "MDVP:APQ": 0.010324296541512012,
      "Shimmer:DDA": -0.003959696274250746,
      "NHR": -0.002755797002464533,
      "HNR": 0.008411232382059097,
      "RPDE": -0.010874859057366848,
      "DFA": 0.002867084462195635,
      "spread1": 0.059926919639110565,
      "spread2": 0.10545971244573593,
      "D2": 0.03051827847957611,
      "PPE": 0.071247898042202
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_17\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 100.0%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: 2.4980\n   Normal Range: Not specified\n   SHAP Impact: 0.1055 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. Pitch Period Entropy (PPE)\n   Patient Value: 2.4946\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0712 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n3. spread1 (spread1)\n   Patient Value: 2.5320\n   Normal Range: Not specified\n   SHAP Impact: 0.0599 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n4. D2 (D2)\n   Patient Value: 1.6386\n   Normal Range: Not specified\n   SHAP Impact: 0.0305 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n5. Recurrence Period Density Entropy (RPDE)\n   Patient Value: 1.2786\n   Normal Range: 0.4-0.7\n   SHAP Impact: -0.0109 (\u2193 decreases PD probability)\n   Clinical Significance: Altered RPDE reflects changes in vocal signal complexity\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_18",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.120075"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9998053908348083,
      "confidence": 0.9998053908348083,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2696347985038301,
      "mean_abs_shap": 0.017291630411240145,
      "features_increasing_pd": 16,
      "features_decreasing_pd": 6
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "MDVP:RAP",
        "feature_value": 0.5957761567004839,
        "shap_value": 0.046122606843709946,
        "contribution": "increases",
        "clinical_name": "MDVP:RAP",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "spread1",
        "feature_value": 0.33089924855460934,
        "shap_value": 0.04411310702562332,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "PPE",
        "feature_value": 0.21911011333670685,
        "shap_value": 0.04166831821203232,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 4,
        "feature_name": "MDVP:Flo(Hz)",
        "feature_value": -1.159203084827597,
        "shap_value": 0.034371934831142426,
        "contribution": "increases",
        "clinical_name": "Minimum Vocal Frequency",
        "normal_range": "65-239 Hz",
        "pd_indication": "Narrowed frequency range indicates motor impairment"
      },
      {
        "rank": 5,
        "feature_name": "HNR",
        "feature_value": -0.43198932608479773,
        "shap_value": 0.030984647572040558,
        "contribution": "increases",
        "clinical_name": "Harmonics-to-Noise Ratio",
        "normal_range": ">13 dB",
        "pd_indication": "Reduced HNR indicates increased vocal noise and hoarseness"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -0.4180729739000429,
      "MDVP:Fhi(Hz)": -0.33419939424189976,
      "MDVP:Flo(Hz)": -1.159203084827597,
      "MDVP:Jitter(%)": 0.6223601132748525,
      "MDVP:Jitter(Abs)": 0.7497594608905653,
      "MDVP:RAP": 0.5957761567004839,
      "MDVP:PPQ": 0.43011880040081596,
      "Jitter:DDP": 0.59456783412418,
      "MDVP:Shimmer": 0.07448070868306447,
      "MDVP:Shimmer(dB)": 0.13246795107123785,
      "Shimmer:APQ3": 0.07068623304884253,
      "Shimmer:APQ5": -0.024035717050338672,
      "MDVP:APQ": 0.11527460375549158,
      "Shimmer:DDA": 0.0706820170200818,
      "NHR": 0.04323296502602676,
      "HNR": -0.43198932608479773,
      "RPDE": -0.0038827010085771578,
      "DFA": 0.1987172753243723,
      "spread1": 0.33089924855460934,
      "spread2": -0.25063037614246214,
      "D2": -0.23641761563713778,
      "PPE": 0.21911011333670685
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.02271112985908985,
      "MDVP:Fhi(Hz)": 0.018626723438501358,
      "MDVP:Flo(Hz)": 0.034371934831142426,
      "MDVP:Jitter(%)": -0.00897968839854002,
      "MDVP:Jitter(Abs)": -0.024131514132022858,
      "MDVP:RAP": 0.046122606843709946,
      "MDVP:PPQ": -0.014938111416995525,
      "Jitter:DDP": 0.030192947015166283,
      "MDVP:Shimmer": 0.005932332947850227,
      "MDVP:Shimmer(dB)": 0.008481981232762337,
      "Shimmer:APQ3": -0.0015453946543857455,
      "Shimmer:APQ5": 0.002806908218190074,
      "MDVP:APQ": 0.009196056053042412,
      "Shimmer:DDA": 0.002051612362265587,
      "NHR": -0.004747950471937656,
      "HNR": 0.030984647572040558,
      "RPDE": -0.0010478761978447437,
      "DFA": 0.01237222459167242,
      "spread1": 0.04411310702562332,
      "spread2": 0.015197318978607655,
      "D2": 0.0001954845938598737,
      "PPE": 0.04166831821203232
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_18\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 100.0%\n\nTOP CONTRIBUTING FEATURES:\n\n1. MDVP:RAP (MDVP:RAP)\n   Patient Value: 0.5958\n   Normal Range: Not specified\n   SHAP Impact: 0.0461 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. spread1 (spread1)\n   Patient Value: 0.3309\n   Normal Range: Not specified\n   SHAP Impact: 0.0441 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Pitch Period Entropy (PPE)\n   Patient Value: 0.2191\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0417 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n4. Minimum Vocal Frequency (MDVP:Flo(Hz))\n   Patient Value: -1.1592\n   Normal Range: 65-239 Hz\n   SHAP Impact: 0.0344 (\u2191 increases PD probability)\n   Clinical Significance: Narrowed frequency range indicates motor impairment\n\n5. Harmonics-to-Noise Ratio (HNR)\n   Patient Value: -0.4320\n   Normal Range: >13 dB\n   SHAP Impact: 0.0310 (\u2191 increases PD probability)\n   Clinical Significance: Reduced HNR indicates increased vocal noise and hoarseness\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_19",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.120487"
    },
    "prediction": {
      "class": "Healthy",
      "probability": 0.02451390027999878,
      "confidence": 0.9754860997200012,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": -0.705656704492867,
      "mean_abs_shap": 0.04132360672916879,
      "features_increasing_pd": 7,
      "features_decreasing_pd": 15
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "PPE",
        "feature_value": -1.1457669320537356,
        "shap_value": -0.1681780368089676,
        "contribution": "decreases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 2,
        "feature_name": "spread1",
        "feature_value": -0.8884186761095476,
        "shap_value": -0.0959172248840332,
        "contribution": "decreases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "HNR",
        "feature_value": 0.7360059093053444,
        "shap_value": -0.08583728969097137,
        "contribution": "decreases",
        "clinical_name": "Harmonics-to-Noise Ratio",
        "normal_range": ">13 dB",
        "pd_indication": "Reduced HNR indicates increased vocal noise and hoarseness"
      },
      {
        "rank": 4,
        "feature_name": "MDVP:RAP",
        "feature_value": -0.6406456026398344,
        "shap_value": -0.0749780684709549,
        "contribution": "decreases",
        "clinical_name": "MDVP:RAP",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 5,
        "feature_name": "Jitter:DDP",
        "feature_value": -0.6418509940178172,
        "shap_value": -0.05204532667994499,
        "contribution": "decreases",
        "clinical_name": "Jitter:DDP",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -0.7214365211108791,
      "MDVP:Fhi(Hz)": -0.679796117051763,
      "MDVP:Flo(Hz)": 0.026961021790779575,
      "MDVP:Jitter(%)": -0.39507554885221957,
      "MDVP:Jitter(Abs)": -0.4018994195636312,
      "MDVP:RAP": -0.6406456026398344,
      "MDVP:PPQ": -0.6455043164110682,
      "Jitter:DDP": -0.6418509940178172,
      "MDVP:Shimmer": -0.4183810735439047,
      "MDVP:Shimmer(dB)": -0.4385873767393471,
      "Shimmer:APQ3": -0.32133144239181544,
      "Shimmer:APQ5": -0.6369016032342638,
      "MDVP:APQ": -0.42781695373136364,
      "Shimmer:DDA": -0.32101120668699173,
      "NHR": -0.4975130093925436,
      "HNR": 0.7360059093053444,
      "RPDE": 0.5266316686160435,
      "DFA": 1.0478349827824336,
      "spread1": -0.8884186761095476,
      "spread2": 0.3364238969358913,
      "D2": -1.41855693339846,
      "PPE": -1.1457669320537356
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": -0.020751183852553368,
      "MDVP:Fhi(Hz)": 0.03043081983923912,
      "MDVP:Flo(Hz)": -0.034285370260477066,
      "MDVP:Jitter(%)": 0.001995765371248126,
      "MDVP:Jitter(Abs)": 0.002977917203679681,
      "MDVP:RAP": -0.0749780684709549,
      "MDVP:PPQ": 0.009766940027475357,
      "Jitter:DDP": -0.05204532667994499,
      "MDVP:Shimmer": -0.039642851799726486,
      "MDVP:Shimmer(dB)": -0.036256831139326096,
      "Shimmer:APQ3": -0.034840211272239685,
      "Shimmer:APQ5": -0.02808351255953312,
      "MDVP:APQ": -0.01916293054819107,
      "Shimmer:DDA": -0.03341628983616829,
      "NHR": 0.014637614600360394,
      "HNR": -0.08583728969097137,
      "RPDE": -0.03420281782746315,
      "DFA": 0.031224984675645828,
      "spread1": -0.0959172248840332,
      "spread2": 0.010697280056774616,
      "D2": -0.04979008063673973,
      "PPE": -0.1681780368089676
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_19\nPREDICTION: Healthy\nCONFIDENCE: 97.5%\n\nTOP CONTRIBUTING FEATURES:\n\n1. Pitch Period Entropy (PPE)\n   Patient Value: -1.1458\n   Normal Range: 0.1-0.3\n   SHAP Impact: -0.1682 (\u2193 decreases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n2. spread1 (spread1)\n   Patient Value: -0.8884\n   Normal Range: Not specified\n   SHAP Impact: -0.0959 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Harmonics-to-Noise Ratio (HNR)\n   Patient Value: 0.7360\n   Normal Range: >13 dB\n   SHAP Impact: -0.0858 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced HNR indicates increased vocal noise and hoarseness\n\n4. MDVP:RAP (MDVP:RAP)\n   Patient Value: -0.6406\n   Normal Range: Not specified\n   SHAP Impact: -0.0750 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n5. Jitter:DDP (Jitter:DDP)\n   Patient Value: -0.6419\n   Normal Range: Not specified\n   SHAP Impact: -0.0520 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_20",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.120915"
    },
    "prediction": {
      "class": "Healthy",
      "probability": 0.0009306209976784885,
      "confidence": 0.9990693926811218,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": -0.7292399420402944,
      "mean_abs_shap": 0.05057632751678201,
      "features_increasing_pd": 8,
      "features_decreasing_pd": 14
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": -1.1884411029745805,
        "shap_value": -0.1902240365743637,
        "contribution": "decreases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "spread1",
        "feature_value": -1.3533818212858482,
        "shap_value": -0.13653074204921722,
        "contribution": "decreases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "PPE",
        "feature_value": -1.2150198183452074,
        "shap_value": -0.13396912813186646,
        "contribution": "decreases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 4,
        "feature_name": "MDVP:Fo(Hz)",
        "feature_value": 2.211069694401727,
        "shap_value": -0.11041400581598282,
        "contribution": "decreases",
        "clinical_name": "Fundamental Frequency",
        "normal_range": "85-180 Hz (male), 165-255 Hz (female)",
        "pd_indication": "Reduced variability indicates vocal rigidity"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Fhi(Hz)",
        "feature_value": 0.7121133676343814,
        "shap_value": -0.0866510197520256,
        "contribution": "decreases",
        "clinical_name": "Maximum Vocal Frequency",
        "normal_range": "102-592 Hz",
        "pd_indication": "Reduced range suggests limited vocal control"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 2.211069694401727,
      "MDVP:Fhi(Hz)": 0.7121133676343814,
      "MDVP:Flo(Hz)": 2.661235440313069,
      "MDVP:Jitter(%)": -0.8003954467727604,
      "MDVP:Jitter(Abs)": -0.9777288597907295,
      "MDVP:RAP": -0.6879404240353656,
      "MDVP:PPQ": -0.7145476921523716,
      "Jitter:DDP": -0.6891457032910083,
      "MDVP:Shimmer": -0.7246252877431864,
      "MDVP:Shimmer(dB)": -0.7266873619410837,
      "Shimmer:APQ3": -0.6521272138593731,
      "Shimmer:APQ5": -0.6760916667045286,
      "MDVP:APQ": -0.7449161637672617,
      "Shimmer:DDA": -0.651810946036243,
      "NHR": -0.4982571552288994,
      "HNR": 0.6152647416437953,
      "RPDE": -0.2994606421874079,
      "DFA": -1.566228577838254,
      "spread1": -1.3533818212858482,
      "spread2": -1.1884411029745805,
      "D2": 0.026965622468475055,
      "PPE": -1.2150198183452074
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": -0.11041400581598282,
      "MDVP:Fhi(Hz)": -0.0866510197520256,
      "MDVP:Flo(Hz)": -0.02451498806476593,
      "MDVP:Jitter(%)": 0.0260747242718935,
      "MDVP:Jitter(Abs)": 0.07292189449071884,
      "MDVP:RAP": -0.027611019089818,
      "MDVP:PPQ": 0.037205539643764496,
      "Jitter:DDP": 0.0032011461444199085,
      "MDVP:Shimmer": -0.003935083281248808,
      "MDVP:Shimmer(dB)": -0.030896203592419624,
      "Shimmer:APQ3": -0.002162669785320759,
      "Shimmer:APQ5": -0.010235600173473358,
      "MDVP:APQ": -0.04505845904350281,
      "Shimmer:DDA": 0.024291768670082092,
      "NHR": 0.016002118587493896,
      "HNR": -0.0538550429046154,
      "RPDE": 0.004775422625243664,
      "DFA": -0.06490157544612885,
      "spread1": -0.13653074204921722,
      "spread2": -0.1902240365743637,
      "D2": 0.007247017230838537,
      "PPE": -0.13396912813186646
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_20\nPREDICTION: Healthy\nCONFIDENCE: 99.9%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: -1.1884\n   Normal Range: Not specified\n   SHAP Impact: -0.1902 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. spread1 (spread1)\n   Patient Value: -1.3534\n   Normal Range: Not specified\n   SHAP Impact: -0.1365 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Pitch Period Entropy (PPE)\n   Patient Value: -1.2150\n   Normal Range: 0.1-0.3\n   SHAP Impact: -0.1340 (\u2193 decreases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n4. Fundamental Frequency (MDVP:Fo(Hz))\n   Patient Value: 2.2111\n   Normal Range: 85-180 Hz (male), 165-255 Hz (female)\n   SHAP Impact: -0.1104 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced variability indicates vocal rigidity\n\n5. Maximum Vocal Frequency (MDVP:Fhi(Hz))\n   Patient Value: 0.7121\n   Normal Range: 102-592 Hz\n   SHAP Impact: -0.0867 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced range suggests limited vocal control\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_21",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.121323"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 1.0,
      "confidence": 1.0,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2698294121073559,
      "mean_abs_shap": 0.014937121352307837,
      "features_increasing_pd": 15,
      "features_decreasing_pd": 7
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "PPE",
        "feature_value": 1.8069536401815551,
        "shap_value": 0.054508380591869354,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 2,
        "feature_name": "spread1",
        "feature_value": 1.4409445577137212,
        "shap_value": 0.043796032667160034,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "spread2",
        "feature_value": 1.2938399622214845,
        "shap_value": 0.031342409551143646,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 4,
        "feature_name": "DFA",
        "feature_value": 1.8323801747840778,
        "shap_value": 0.027239928022027016,
        "contribution": "increases",
        "clinical_name": "Detrended Fluctuation Analysis",
        "normal_range": "0.6-0.7",
        "pd_indication": "Abnormal DFA indicates disrupted vocal control dynamics"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Shimmer",
        "feature_value": 1.3403964621700262,
        "shap_value": 0.018873298540711403,
        "contribution": "increases",
        "clinical_name": "Shimmer",
        "normal_range": "<3.81%",
        "pd_indication": "Elevated shimmer indicates amplitude perturbation and weak voice"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -0.9096217173964893,
      "MDVP:Fhi(Hz)": -0.6490915061914281,
      "MDVP:Flo(Hz)": -0.11422869698461874,
      "MDVP:Jitter(%)": 0.7753890543264852,
      "MDVP:Jitter(Abs)": 1.325588901117664,
      "MDVP:RAP": 0.5788851490592228,
      "MDVP:PPQ": 1.2840763424643054,
      "Jitter:DDP": 0.5776768665266117,
      "MDVP:Shimmer": 1.3403964621700262,
      "MDVP:Shimmer(dB)": 1.2076982529848619,
      "Shimmer:APQ3": 1.3405470154586314,
      "Shimmer:APQ5": 1.84874901814571,
      "MDVP:APQ": 0.806858515195724,
      "Shimmer:DDA": 1.3402288773883022,
      "NHR": -0.2807185224008782,
      "HNR": -0.28134603059712454,
      "RPDE": -0.6131336172277281,
      "DFA": 1.8323801747840778,
      "spread1": 1.4409445577137212,
      "spread2": 1.2938399622214845,
      "D2": 0.06214484817782002,
      "PPE": 1.8069536401815551
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.0035887497942894697,
      "MDVP:Fhi(Hz)": 0.011498000472784042,
      "MDVP:Flo(Hz)": -0.00032472354359924793,
      "MDVP:Jitter(%)": -0.0058540599420666695,
      "MDVP:Jitter(Abs)": -0.013088010251522064,
      "MDVP:RAP": 0.016849583014845848,
      "MDVP:PPQ": -0.006863547023385763,
      "Jitter:DDP": 0.010573215782642365,
      "MDVP:Shimmer": 0.018873298540711403,
      "MDVP:Shimmer(dB)": 0.016563856974244118,
      "Shimmer:APQ3": 0.015818921849131584,
      "Shimmer:APQ5": 0.015223195776343346,
      "MDVP:APQ": 0.007836109027266502,
      "Shimmer:DDA": 0.011495395563542843,
      "NHR": -0.0004994415212422609,
      "HNR": 0.014015963301062584,
      "RPDE": -0.0020628576166927814,
      "DFA": 0.027239928022027016,
      "spread1": 0.043796032667160034,
      "spread2": 0.031342409551143646,
      "D2": -0.0007009889231994748,
      "PPE": 0.054508380591869354
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_21\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 100.0%\n\nTOP CONTRIBUTING FEATURES:\n\n1. Pitch Period Entropy (PPE)\n   Patient Value: 1.8070\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0545 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n2. spread1 (spread1)\n   Patient Value: 1.4409\n   Normal Range: Not specified\n   SHAP Impact: 0.0438 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. spread2 (spread2)\n   Patient Value: 1.2938\n   Normal Range: Not specified\n   SHAP Impact: 0.0313 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n4. Detrended Fluctuation Analysis (DFA)\n   Patient Value: 1.8324\n   Normal Range: 0.6-0.7\n   SHAP Impact: 0.0272 (\u2191 increases PD probability)\n   Clinical Significance: Abnormal DFA indicates disrupted vocal control dynamics\n\n5. Shimmer (MDVP:Shimmer)\n   Patient Value: 1.3404\n   Normal Range: <3.81%\n   SHAP Impact: 0.0189 (\u2191 increases PD probability)\n   Clinical Significance: Elevated shimmer indicates amplitude perturbation and weak voice\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_22",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.121707"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.987784206867218,
      "confidence": 0.987784206867218,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2576136239513289,
      "mean_abs_shap": 0.013927356658810326,
      "features_increasing_pd": 16,
      "features_decreasing_pd": 6
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "RPDE",
        "feature_value": -1.659568653794435,
        "shap_value": 0.07551605254411697,
        "contribution": "increases",
        "clinical_name": "Recurrence Period Density Entropy",
        "normal_range": "0.4-0.7",
        "pd_indication": "Altered RPDE reflects changes in vocal signal complexity"
      },
      {
        "rank": 2,
        "feature_name": "D2",
        "feature_value": -0.020305807313238156,
        "shap_value": 0.05759808048605919,
        "contribution": "increases",
        "clinical_name": "D2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "MDVP:Fo(Hz)",
        "feature_value": 0.7735324510033329,
        "shap_value": 0.043114256113767624,
        "contribution": "increases",
        "clinical_name": "Fundamental Frequency",
        "normal_range": "85-180 Hz (male), 165-255 Hz (female)",
        "pd_indication": "Reduced variability indicates vocal rigidity"
      },
      {
        "rank": 4,
        "feature_name": "spread2",
        "feature_value": -0.30550368701929353,
        "shap_value": 0.025146419182419777,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Fhi(Hz)",
        "feature_value": 0.006783966265250621,
        "shap_value": 0.01635425165295601,
        "contribution": "increases",
        "clinical_name": "Maximum Vocal Frequency",
        "normal_range": "102-592 Hz",
        "pd_indication": "Reduced range suggests limited vocal control"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 0.7735324510033329,
      "MDVP:Fhi(Hz)": 0.006783966265250621,
      "MDVP:Flo(Hz)": 1.4111915669849227,
      "MDVP:Jitter(%)": -0.6701140510125865,
      "MDVP:Jitter(Abs)": -0.6898141396771803,
      "MDVP:RAP": -0.5595687659617807,
      "MDVP:PPQ": -0.6164334213620983,
      "Jitter:DDP": -0.5585222205364804,
      "MDVP:Shimmer": -0.7847044478204761,
      "MDVP:Shimmer(dB)": -0.7575552174984126,
      "Shimmer:APQ3": -0.7824706223182317,
      "Shimmer:APQ5": -0.7061095876604758,
      "MDVP:APQ": -0.695221511448203,
      "Shimmer:DDA": -0.7828142258979364,
      "NHR": -0.5590290651979589,
      "HNR": 1.1181641641740732,
      "RPDE": -1.659568653794435,
      "DFA": 0.8610385084963295,
      "spread1": -0.8855752191720471,
      "spread2": -0.30550368701929353,
      "D2": -0.020305807313238156,
      "PPE": -0.8454708421475995
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.043114256113767624,
      "MDVP:Fhi(Hz)": 0.01635425165295601,
      "MDVP:Flo(Hz)": 0.002614381955936551,
      "MDVP:Jitter(%)": 0.008065680041909218,
      "MDVP:Jitter(Abs)": 0.015793614089488983,
      "MDVP:RAP": -0.0005299955373629928,
      "MDVP:PPQ": 0.005715159699320793,
      "Jitter:DDP": 0.0016333551611751318,
      "MDVP:Shimmer": 0.0017236811108887196,
      "MDVP:Shimmer(dB)": -0.0021436777897179127,
      "Shimmer:APQ3": 0.004769232589751482,
      "Shimmer:APQ5": -0.00029965213616378605,
      "MDVP:APQ": -0.004033664241433144,
      "Shimmer:DDA": 0.00960405170917511,
      "NHR": 0.004105682950466871,
      "HNR": -0.015801630914211273,
      "RPDE": 0.07551605254411697,
      "DFA": 0.006102621089667082,
      "spread1": 0.004151214845478535,
      "spread2": 0.025146419182419777,
      "D2": 0.05759808048605919,
      "PPE": -0.001585490652360022
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_22\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 98.8%\n\nTOP CONTRIBUTING FEATURES:\n\n1. Recurrence Period Density Entropy (RPDE)\n   Patient Value: -1.6596\n   Normal Range: 0.4-0.7\n   SHAP Impact: 0.0755 (\u2191 increases PD probability)\n   Clinical Significance: Altered RPDE reflects changes in vocal signal complexity\n\n2. D2 (D2)\n   Patient Value: -0.0203\n   Normal Range: Not specified\n   SHAP Impact: 0.0576 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Fundamental Frequency (MDVP:Fo(Hz))\n   Patient Value: 0.7735\n   Normal Range: 85-180 Hz (male), 165-255 Hz (female)\n   SHAP Impact: 0.0431 (\u2191 increases PD probability)\n   Clinical Significance: Reduced variability indicates vocal rigidity\n\n4. spread2 (spread2)\n   Patient Value: -0.3055\n   Normal Range: Not specified\n   SHAP Impact: 0.0251 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n5. Maximum Vocal Frequency (MDVP:Fhi(Hz))\n   Patient Value: 0.0068\n   Normal Range: 102-592 Hz\n   SHAP Impact: 0.0164 (\u2191 increases PD probability)\n   Clinical Significance: Reduced range suggests limited vocal control\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_23",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.122112"
    },
    "prediction": {
      "class": "Healthy",
      "probability": 0.2776012420654297,
      "confidence": 0.7223987579345703,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": -0.452569360146299,
      "mean_abs_shap": 0.03857948680789294,
      "features_increasing_pd": 6,
      "features_decreasing_pd": 16
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "MDVP:Fo(Hz)",
        "feature_value": 1.4548166356769172,
        "shap_value": -0.12432610243558884,
        "contribution": "decreases",
        "clinical_name": "Fundamental Frequency",
        "normal_range": "85-180 Hz (male), 165-255 Hz (female)",
        "pd_indication": "Reduced variability indicates vocal rigidity"
      },
      {
        "rank": 2,
        "feature_name": "MDVP:Fhi(Hz)",
        "feature_value": 0.6922463228485903,
        "shap_value": -0.11908572912216187,
        "contribution": "decreases",
        "clinical_name": "Maximum Vocal Frequency",
        "normal_range": "102-592 Hz",
        "pd_indication": "Reduced range suggests limited vocal control"
      },
      {
        "rank": 3,
        "feature_name": "D2",
        "feature_value": 0.45480231214611794,
        "shap_value": 0.08686723560094833,
        "contribution": "increases",
        "clinical_name": "D2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 4,
        "feature_name": "spread2",
        "feature_value": -0.4308528405403441,
        "shap_value": -0.07751024514436722,
        "contribution": "decreases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 5,
        "feature_name": "PPE",
        "feature_value": -0.6450546579643281,
        "shap_value": -0.06155725568532944,
        "contribution": "decreases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 1.4548166356769172,
      "MDVP:Fhi(Hz)": 0.6922463228485903,
      "MDVP:Flo(Hz)": -0.8834811491084354,
      "MDVP:Jitter(%)": -0.11383317070327284,
      "MDVP:Jitter(Abs)": -0.4018994195636312,
      "MDVP:RAP": -0.12040256728899011,
      "MDVP:PPQ": -0.10042503424288357,
      "Jitter:DDP": -0.12048312750620994,
      "MDVP:Shimmer": -0.577883268439364,
      "MDVP:Shimmer(dB)": -0.4745998748895642,
      "Shimmer:APQ3": -0.5336332061695017,
      "Shimmer:APQ5": -0.5226667373741308,
      "MDVP:APQ": -0.6123970909164387,
      "Shimmer:DDA": -0.5336446709851175,
      "NHR": 0.47458950150029,
      "HNR": -0.15335586225045433,
      "RPDE": -0.34465964467937993,
      "DFA": -0.9736978411697008,
      "spread1": -0.03647134145403148,
      "spread2": -0.4308528405403441,
      "D2": 0.45480231214611794,
      "PPE": -0.6450546579643281
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": -0.12432610243558884,
      "MDVP:Fhi(Hz)": -0.11908572912216187,
      "MDVP:Flo(Hz)": 0.05761752277612686,
      "MDVP:Jitter(%)": -0.020937349647283554,
      "MDVP:Jitter(Abs)": 0.006370672956109047,
      "MDVP:RAP": -0.009106326848268509,
      "MDVP:PPQ": -0.04865138232707977,
      "Jitter:DDP": -0.023185856640338898,
      "MDVP:Shimmer": -0.0210302472114563,
      "MDVP:Shimmer(dB)": -0.025306766852736473,
      "Shimmer:APQ3": -0.014202704653143883,
      "Shimmer:APQ5": -0.019105015322566032,
      "MDVP:APQ": -0.029822802171111107,
      "Shimmer:DDA": 0.0017939151730388403,
      "NHR": -0.021637432277202606,
      "HNR": 0.011416015215218067,
      "RPDE": -0.02068222127854824,
      "DFA": -0.014511597342789173,
      "spread1": 0.03402431309223175,
      "spread2": -0.07751024514436722,
      "D2": 0.08686723560094833,
      "PPE": -0.06155725568532944
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_23\nPREDICTION: Healthy\nCONFIDENCE: 72.2%\n\nTOP CONTRIBUTING FEATURES:\n\n1. Fundamental Frequency (MDVP:Fo(Hz))\n   Patient Value: 1.4548\n   Normal Range: 85-180 Hz (male), 165-255 Hz (female)\n   SHAP Impact: -0.1243 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced variability indicates vocal rigidity\n\n2. Maximum Vocal Frequency (MDVP:Fhi(Hz))\n   Patient Value: 0.6922\n   Normal Range: 102-592 Hz\n   SHAP Impact: -0.1191 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced range suggests limited vocal control\n\n3. D2 (D2)\n   Patient Value: 0.4548\n   Normal Range: Not specified\n   SHAP Impact: 0.0869 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n4. spread2 (spread2)\n   Patient Value: -0.4309\n   Normal Range: Not specified\n   SHAP Impact: -0.0775 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n5. Pitch Period Entropy (PPE)\n   Patient Value: -0.6451\n   Normal Range: 0.1-0.3\n   SHAP Impact: -0.0616 (\u2193 decreases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_24",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.122518"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 1.0,
      "confidence": 1.0,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2698294068686664,
      "mean_abs_shap": 0.01479440502060408,
      "features_increasing_pd": 18,
      "features_decreasing_pd": 4
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": 1.1284146600775733,
        "shap_value": 0.042559415102005005,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "HNR",
        "feature_value": -1.0932341073306906,
        "shap_value": 0.041203297674655914,
        "contribution": "increases",
        "clinical_name": "Harmonics-to-Noise Ratio",
        "normal_range": ">13 dB",
        "pd_indication": "Reduced HNR indicates increased vocal noise and hoarseness"
      },
      {
        "rank": 3,
        "feature_name": "PPE",
        "feature_value": 0.4063765928458383,
        "shap_value": 0.036957673728466034,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 4,
        "feature_name": "spread1",
        "feature_value": 0.3522831114807764,
        "shap_value": 0.031182684004306793,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Fhi(Hz)",
        "feature_value": -0.9240741988856607,
        "shap_value": 0.020565850660204887,
        "contribution": "increases",
        "clinical_name": "Maximum Vocal Frequency",
        "normal_range": "102-592 Hz",
        "pd_indication": "Reduced range suggests limited vocal control"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -1.1557230939265193,
      "MDVP:Fhi(Hz)": -0.9240741988856607,
      "MDVP:Flo(Hz)": -0.5348952746575746,
      "MDVP:Jitter(%)": -0.06833808012035486,
      "MDVP:Jitter(Abs)": 0.4618447407770164,
      "MDVP:RAP": -0.1339153734019991,
      "MDVP:PPQ": -0.09315731048064109,
      "Jitter:DDP": -0.1339959015842646,
      "MDVP:Shimmer": 1.0426590316985025,
      "MDVP:Shimmer(dB)": 0.8167054159253623,
      "Shimmer:APQ3": 1.1025715500148063,
      "Shimmer:APQ5": 1.1041378122106824,
      "MDVP:APQ": 0.735274551736128,
      "Shimmer:DDA": 1.102908865377546,
      "NHR": 0.13550704873414982,
      "HNR": -1.0932341073306906,
      "RPDE": 1.3434160328969265,
      "DFA": 0.4704327675521813,
      "spread1": 0.3522831114807764,
      "spread2": 1.1284146600775733,
      "D2": -0.017516507478481158,
      "PPE": 0.4063765928458383
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.004159606993198395,
      "MDVP:Fhi(Hz)": 0.020565850660204887,
      "MDVP:Flo(Hz)": 0.0037581888027489185,
      "MDVP:Jitter(%)": -0.0038606321904808283,
      "MDVP:Jitter(Abs)": -0.016728462651371956,
      "MDVP:RAP": 0.006970214191824198,
      "MDVP:PPQ": -0.003948040772229433,
      "Jitter:DDP": 0.004146829713135958,
      "MDVP:Shimmer": 0.01913294941186905,
      "MDVP:Shimmer(dB)": 0.018311915919184685,
      "Shimmer:APQ3": 0.01359387394040823,
      "Shimmer:APQ5": 0.015647178515791893,
      "MDVP:APQ": 0.011430565267801285,
      "Shimmer:DDA": 0.010471335612237453,
      "NHR": -0.003286616178229451,
      "HNR": 0.041203297674655914,
      "RPDE": 0.0061530983075499535,
      "DFA": 0.00925828143954277,
      "spread1": 0.031182684004306793,
      "spread2": 0.042559415102005005,
      "D2": 0.0021501993760466576,
      "PPE": 0.036957673728466034
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_24\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 100.0%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: 1.1284\n   Normal Range: Not specified\n   SHAP Impact: 0.0426 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. Harmonics-to-Noise Ratio (HNR)\n   Patient Value: -1.0932\n   Normal Range: >13 dB\n   SHAP Impact: 0.0412 (\u2191 increases PD probability)\n   Clinical Significance: Reduced HNR indicates increased vocal noise and hoarseness\n\n3. Pitch Period Entropy (PPE)\n   Patient Value: 0.4064\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0370 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n4. spread1 (spread1)\n   Patient Value: 0.3523\n   Normal Range: Not specified\n   SHAP Impact: 0.0312 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n5. Maximum Vocal Frequency (MDVP:Fhi(Hz))\n   Patient Value: -0.9241\n   Normal Range: 102-592 Hz\n   SHAP Impact: 0.0206 (\u2191 increases PD probability)\n   Clinical Significance: Reduced range suggests limited vocal control\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_25",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.122946"
    },
    "prediction": {
      "class": "Healthy",
      "probability": 0.0077932169660925865,
      "confidence": 0.9922068119049072,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": -0.7223774176090956,
      "mean_abs_shap": 0.03819525567814708,
      "features_increasing_pd": 4,
      "features_decreasing_pd": 18
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": -0.8008059377706256,
        "shap_value": -0.12668941915035248,
        "contribution": "decreases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "PPE",
        "feature_value": -1.0425606627965496,
        "shap_value": -0.09979911148548126,
        "contribution": "decreases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 3,
        "feature_name": "MDVP:Fhi(Hz)",
        "feature_value": 0.7188745185625852,
        "shap_value": -0.09941074997186661,
        "contribution": "decreases",
        "clinical_name": "Maximum Vocal Frequency",
        "normal_range": "102-592 Hz",
        "pd_indication": "Reduced range suggests limited vocal control"
      },
      {
        "rank": 4,
        "feature_name": "spread1",
        "feature_value": -1.1495927707476643,
        "shap_value": -0.09117691963911057,
        "contribution": "decreases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Fo(Hz)",
        "feature_value": 1.1516710916539525,
        "shap_value": -0.08864828199148178,
        "contribution": "decreases",
        "clinical_name": "Fundamental Frequency",
        "normal_range": "85-180 Hz (male), 165-255 Hz (female)",
        "pd_indication": "Reduced variability indicates vocal rigidity"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 1.1516710916539525,
      "MDVP:Fhi(Hz)": 0.7188745185625852,
      "MDVP:Flo(Hz)": -0.8776068827864048,
      "MDVP:Jitter(%)": 0.14879757947993483,
      "MDVP:Jitter(Abs)": -0.4018994195636312,
      "MDVP:RAP": 0.2748470115165217,
      "MDVP:PPQ": 0.18665005436569362,
      "Jitter:DDP": 0.2736394497703829,
      "MDVP:Shimmer": -0.21102822017980763,
      "MDVP:Shimmer(dB)": -0.14019810635183422,
      "Shimmer:APQ3": -0.11100457874229347,
      "Shimmer:APQ5": -0.17162382841707988,
      "MDVP:APQ": -0.3846299344540866,
      "Shimmer:DDA": -0.11068182017537832,
      "NHR": 0.4852555918213902,
      "HNR": -0.5703999329163294,
      "RPDE": 0.09591006036187673,
      "DFA": -0.6221363681291978,
      "spread1": -1.1495927707476643,
      "spread2": -0.8008059377706256,
      "D2": -0.17149633460056574,
      "PPE": -1.0425606627965496
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": -0.08864828199148178,
      "MDVP:Fhi(Hz)": -0.09941074997186661,
      "MDVP:Flo(Hz)": 0.02904827892780304,
      "MDVP:Jitter(%)": -0.013520224951207638,
      "MDVP:Jitter(Abs)": 0.002971569076180458,
      "MDVP:RAP": 0.0051919627003371716,
      "MDVP:PPQ": -0.030393021181225777,
      "Jitter:DDP": -0.011266788467764854,
      "MDVP:Shimmer": -0.025737974792718887,
      "MDVP:Shimmer(dB)": -0.020745914429426193,
      "Shimmer:APQ3": -0.026733841747045517,
      "Shimmer:APQ5": -0.01688149757683277,
      "MDVP:APQ": -0.018057281151413918,
      "Shimmer:DDA": -0.023585330694913864,
      "NHR": -0.011468085460364819,
      "HNR": 0.021747292950749397,
      "RPDE": -0.027543209493160248,
      "DFA": -0.048151642084121704,
      "spread1": -0.09117691963911057,
      "spread2": -0.12668941915035248,
      "D2": -0.001527226995676756,
      "PPE": -0.09979911148548126
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_25\nPREDICTION: Healthy\nCONFIDENCE: 99.2%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: -0.8008\n   Normal Range: Not specified\n   SHAP Impact: -0.1267 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. Pitch Period Entropy (PPE)\n   Patient Value: -1.0426\n   Normal Range: 0.1-0.3\n   SHAP Impact: -0.0998 (\u2193 decreases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n3. Maximum Vocal Frequency (MDVP:Fhi(Hz))\n   Patient Value: 0.7189\n   Normal Range: 102-592 Hz\n   SHAP Impact: -0.0994 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced range suggests limited vocal control\n\n4. spread1 (spread1)\n   Patient Value: -1.1496\n   Normal Range: Not specified\n   SHAP Impact: -0.0912 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n5. Fundamental Frequency (MDVP:Fo(Hz))\n   Patient Value: 1.1517\n   Normal Range: 85-180 Hz (male), 165-255 Hz (female)\n   SHAP Impact: -0.0886 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced variability indicates vocal rigidity\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_26",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.123356"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9996009469032288,
      "confidence": 0.9996009469032288,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2694304028818806,
      "mean_abs_shap": 0.01837247707139382,
      "features_increasing_pd": 12,
      "features_decreasing_pd": 10
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": 1.217173592720404,
        "shap_value": 0.08630087971687317,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "PPE",
        "feature_value": 0.27833940917860167,
        "shap_value": 0.06671012938022614,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 3,
        "feature_name": "spread1",
        "feature_value": 0.17079018430925072,
        "shap_value": 0.04833782836794853,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 4,
        "feature_name": "MDVP:Jitter(Abs)",
        "feature_value": 0.4618447407770164,
        "shap_value": -0.038007065653800964,
        "contribution": "decreases",
        "clinical_name": "Absolute Jitter",
        "normal_range": "<83 microseconds",
        "pd_indication": "Increased jitter reflects neuromuscular instability"
      },
      {
        "rank": 5,
        "feature_name": "HNR",
        "feature_value": -0.01675750559020276,
        "shap_value": 0.028881730511784554,
        "contribution": "increases",
        "clinical_name": "Harmonics-to-Noise Ratio",
        "normal_range": ">13 dB",
        "pd_indication": "Reduced HNR indicates increased vocal noise and hoarseness"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -1.416987803301805,
      "MDVP:Fhi(Hz)": -0.7126813908532846,
      "MDVP:Flo(Hz)": -0.5660173679950786,
      "MDVP:Jitter(%)": -0.1469205093090312,
      "MDVP:Jitter(Abs)": 0.4618447407770164,
      "MDVP:RAP": -0.12715897034549462,
      "MDVP:PPQ": -0.04591710602606513,
      "Jitter:DDP": -0.12611345003873267,
      "MDVP:Shimmer": -0.46676340599552724,
      "MDVP:Shimmer(dB)": -0.469455232296676,
      "Shimmer:APQ3": -0.48722305315763537,
      "Shimmer:APQ5": -0.4259423254049672,
      "MDVP:APQ": -0.40888565760981743,
      "Shimmer:DDA": -0.4875631152548735,
      "NHR": -0.35091627963044497,
      "HNR": -0.01675750559020276,
      "RPDE": 1.128677366128087,
      "DFA": 1.0053301788372158,
      "spread1": 0.17079018430925072,
      "spread2": 1.217173592720404,
      "D2": -0.15534982428950853,
      "PPE": 0.27833940917860167
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": -0.009324162267148495,
      "MDVP:Fhi(Hz)": 0.024331962689757347,
      "MDVP:Flo(Hz)": 0.014924982562661171,
      "MDVP:Jitter(%)": -0.00671621086075902,
      "MDVP:Jitter(Abs)": -0.038007065653800964,
      "MDVP:RAP": 0.016431899741292,
      "MDVP:PPQ": -0.007609245367348194,
      "Jitter:DDP": 0.011336625553667545,
      "MDVP:Shimmer": -0.0013488540425896645,
      "MDVP:Shimmer(dB)": -9.921323908201884e-06,
      "Shimmer:APQ3": -0.0021613172721117735,
      "Shimmer:APQ5": -0.000404042104491964,
      "MDVP:APQ": 0.001917524728924036,
      "Shimmer:DDA": -0.000909220427274704,
      "NHR": 9.829744521994144e-05,
      "HNR": 0.028881730511784554,
      "RPDE": -0.0008920070249587297,
      "DFA": 0.027779527008533478,
      "spread1": 0.04833782836794853,
      "spread2": 0.08630087971687317,
      "D2": 0.009761061519384384,
      "PPE": 0.06671012938022614
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_26\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 100.0%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: 1.2172\n   Normal Range: Not specified\n   SHAP Impact: 0.0863 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. Pitch Period Entropy (PPE)\n   Patient Value: 0.2783\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0667 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n3. spread1 (spread1)\n   Patient Value: 0.1708\n   Normal Range: Not specified\n   SHAP Impact: 0.0483 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n4. Absolute Jitter (MDVP:Jitter(Abs))\n   Patient Value: 0.4618\n   Normal Range: <83 microseconds\n   SHAP Impact: -0.0380 (\u2193 decreases PD probability)\n   Clinical Significance: Increased jitter reflects neuromuscular instability\n\n5. Harmonics-to-Noise Ratio (HNR)\n   Patient Value: -0.0168\n   Normal Range: >13 dB\n   SHAP Impact: 0.0289 (\u2191 increases PD probability)\n   Clinical Significance: Reduced HNR indicates increased vocal noise and hoarseness\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_27",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.123795"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9978324770927429,
      "confidence": 0.9978324770927429,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2676618824261823,
      "mean_abs_shap": 0.013206277806272159,
      "features_increasing_pd": 16,
      "features_decreasing_pd": 6
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": 0.48540523647750083,
        "shap_value": 0.06939166784286499,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "D2",
        "feature_value": 0.0018802573818085815,
        "shap_value": 0.04699834808707237,
        "contribution": "increases",
        "clinical_name": "D2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "MDVP:Fo(Hz)",
        "feature_value": 0.8115618959986228,
        "shap_value": 0.038056448101997375,
        "contribution": "increases",
        "clinical_name": "Fundamental Frequency",
        "normal_range": "85-180 Hz (male), 165-255 Hz (female)",
        "pd_indication": "Reduced variability indicates vocal rigidity"
      },
      {
        "rank": 4,
        "feature_name": "spread1",
        "feature_value": -0.2963469363522543,
        "shap_value": 0.03487636521458626,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 5,
        "feature_name": "RPDE",
        "feature_value": -0.981361768984778,
        "shap_value": 0.021918542683124542,
        "contribution": "increases",
        "clinical_name": "Recurrence Period Density Entropy",
        "normal_range": "0.4-0.7",
        "pd_indication": "Altered RPDE reflects changes in vocal signal complexity"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 0.8115618959986228,
      "MDVP:Fhi(Hz)": 0.057191250332895315,
      "MDVP:Flo(Hz)": 1.3059385362972415,
      "MDVP:Jitter(%)": -0.6328907950811082,
      "MDVP:Jitter(Abs)": -0.6898141396771803,
      "MDVP:RAP": -0.549434161377024,
      "MDVP:PPQ": -0.5909963881942497,
      "Jitter:DDP": -0.5495137044844439,
      "MDVP:Shimmer": -0.695383218679019,
      "MDVP:Shimmer(dB)": -0.6752409360122023,
      "Shimmer:APQ3": -0.7281608687937072,
      "Shimmer:APQ5": -0.6544120571252331,
      "MDVP:APQ": -0.6165383119430268,
      "Shimmer:DDA": -0.7278455129911455,
      "NHR": -0.5505954123859262,
      "HNR": 1.002180153212135,
      "RPDE": -0.981361768984778,
      "DFA": 0.7287953013368441,
      "spread1": -0.2963469363522543,
      "spread2": 0.48540523647750083,
      "D2": 0.0018802573818085815,
      "PPE": -0.5101978728036503
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.038056448101997375,
      "MDVP:Fhi(Hz)": 0.011321494355797768,
      "MDVP:Flo(Hz)": 0.0018744112458080053,
      "MDVP:Jitter(%)": 0.004047574941068888,
      "MDVP:Jitter(Abs)": 0.013960839249193668,
      "MDVP:RAP": 2.830260928021744e-05,
      "MDVP:PPQ": 0.0034720376133918762,
      "Jitter:DDP": 0.0015977583825588226,
      "MDVP:Shimmer": -0.00020114658400416374,
      "MDVP:Shimmer(dB)": -0.0015020440332591534,
      "Shimmer:APQ3": 0.0017994008958339691,
      "Shimmer:APQ5": -0.000696568051353097,
      "MDVP:APQ": -0.0002933442301582545,
      "Shimmer:DDA": 0.005304571241140366,
      "NHR": 0.0026573101058602333,
      "HNR": -0.008308636955916882,
      "RPDE": 0.021918542683124542,
      "DFA": -0.0004363748012110591,
      "spread1": 0.03487636521458626,
      "spread2": 0.06939166784286499,
      "D2": 0.04699834808707237,
      "PPE": 0.02179492451250553
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_27\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 99.8%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: 0.4854\n   Normal Range: Not specified\n   SHAP Impact: 0.0694 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. D2 (D2)\n   Patient Value: 0.0019\n   Normal Range: Not specified\n   SHAP Impact: 0.0470 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Fundamental Frequency (MDVP:Fo(Hz))\n   Patient Value: 0.8116\n   Normal Range: 85-180 Hz (male), 165-255 Hz (female)\n   SHAP Impact: 0.0381 (\u2191 increases PD probability)\n   Clinical Significance: Reduced variability indicates vocal rigidity\n\n4. spread1 (spread1)\n   Patient Value: -0.2963\n   Normal Range: Not specified\n   SHAP Impact: 0.0349 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n5. Recurrence Period Density Entropy (RPDE)\n   Patient Value: -0.9814\n   Normal Range: 0.4-0.7\n   SHAP Impact: 0.0219 (\u2191 increases PD probability)\n   Clinical Significance: Altered RPDE reflects changes in vocal signal complexity\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_28",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.124197"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9997430443763733,
      "confidence": 0.9997430443763733,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.26957247755490243,
      "mean_abs_shap": 0.02090015682518821,
      "features_increasing_pd": 15,
      "features_decreasing_pd": 7
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread1",
        "feature_value": 1.9318170029408461,
        "shap_value": 0.14263182878494263,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "MDVP:Fhi(Hz)",
        "feature_value": -0.7643926894435488,
        "shap_value": 0.03734311833977699,
        "contribution": "increases",
        "clinical_name": "Maximum Vocal Frequency",
        "normal_range": "102-592 Hz",
        "pd_indication": "Reduced range suggests limited vocal control"
      },
      {
        "rank": 3,
        "feature_name": "PPE",
        "feature_value": -0.0032889950733835105,
        "shap_value": 0.036787498742341995,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 4,
        "feature_name": "MDVP:Jitter(Abs)",
        "feature_value": 0.17393002066346724,
        "shap_value": -0.031008753925561905,
        "contribution": "decreases",
        "clinical_name": "Absolute Jitter",
        "normal_range": "<83 microseconds",
        "pd_indication": "Increased jitter reflects neuromuscular instability"
      },
      {
        "rank": 5,
        "feature_name": "RPDE",
        "feature_value": 1.2516483611708005,
        "shap_value": -0.027236877009272575,
        "contribution": "decreases",
        "clinical_name": "Recurrence Period Density Entropy",
        "normal_range": "0.4-0.7",
        "pd_indication": "Altered RPDE reflects changes in vocal signal complexity"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -0.8806999611389248,
      "MDVP:Fhi(Hz)": -0.7643926894435488,
      "MDVP:Flo(Hz)": -0.47617564777578486,
      "MDVP:Jitter(%)": 0.05160352232551943,
      "MDVP:Jitter(Abs)": 0.17393002066346724,
      "MDVP:RAP": 0.08566772593439624,
      "MDVP:PPQ": -0.1622006862219445,
      "Jitter:DDP": 0.08446061267761841,
      "MDVP:Shimmer": 0.06172053309142788,
      "MDVP:Shimmer(dB)": -0.032160611901182905,
      "Shimmer:APQ3": 0.09142268439457021,
      "Shimmer:APQ5": 0.013486684144595433,
      "MDVP:APQ": -0.0036376000079702563,
      "Shimmer:DDA": 0.09141871709869152,
      "NHR": 0.036287603886705704,
      "HNR": 0.12346535141260899,
      "RPDE": 1.2516483611708005,
      "DFA": -1.1971288907231687,
      "spread1": 1.9318170029408461,
      "spread2": -0.2235363032582614,
      "D2": 0.15130553763756108,
      "PPE": -0.0032889950733835105
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.02284710481762886,
      "MDVP:Fhi(Hz)": 0.03734311833977699,
      "MDVP:Flo(Hz)": 0.0089951166883111,
      "MDVP:Jitter(%)": -0.007310992106795311,
      "MDVP:Jitter(Abs)": -0.031008753925561905,
      "MDVP:RAP": 0.01807357370853424,
      "MDVP:PPQ": -0.010331910103559494,
      "Jitter:DDP": 0.011226550675928593,
      "MDVP:Shimmer": 0.00830258522182703,
      "MDVP:Shimmer(dB)": 0.01096808910369873,
      "Shimmer:APQ3": 0.001997120212763548,
      "Shimmer:APQ5": 0.0039616962894797325,
      "MDVP:APQ": 0.008083823136985302,
      "Shimmer:DDA": -0.0026858204510062933,
      "NHR": -0.006152297370135784,
      "HNR": 0.015103123150765896,
      "RPDE": -0.027236877009272575,
      "DFA": -0.010388835333287716,
      "spread1": 0.14263182878494263,
      "spread2": 0.021144414320588112,
      "D2": 0.017222320660948753,
      "PPE": 0.036787498742341995
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_28\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 100.0%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread1 (spread1)\n   Patient Value: 1.9318\n   Normal Range: Not specified\n   SHAP Impact: 0.1426 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. Maximum Vocal Frequency (MDVP:Fhi(Hz))\n   Patient Value: -0.7644\n   Normal Range: 102-592 Hz\n   SHAP Impact: 0.0373 (\u2191 increases PD probability)\n   Clinical Significance: Reduced range suggests limited vocal control\n\n3. Pitch Period Entropy (PPE)\n   Patient Value: -0.0033\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0368 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n4. Absolute Jitter (MDVP:Jitter(Abs))\n   Patient Value: 0.1739\n   Normal Range: <83 microseconds\n   SHAP Impact: -0.0310 (\u2193 decreases PD probability)\n   Clinical Significance: Increased jitter reflects neuromuscular instability\n\n5. Recurrence Period Density Entropy (RPDE)\n   Patient Value: 1.2516\n   Normal Range: 0.4-0.7\n   SHAP Impact: -0.0272 (\u2193 decreases PD probability)\n   Clinical Significance: Altered RPDE reflects changes in vocal signal complexity\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_29",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.124607"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9967808723449707,
      "confidence": 0.9967808723449707,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2666103488445515,
      "mean_abs_shap": 0.0185510090463636,
      "features_increasing_pd": 14,
      "features_decreasing_pd": 8
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "HNR",
        "feature_value": -0.805539392639946,
        "shap_value": 0.08642543852329254,
        "contribution": "increases",
        "clinical_name": "Harmonics-to-Noise Ratio",
        "normal_range": ">13 dB",
        "pd_indication": "Reduced HNR indicates increased vocal noise and hoarseness"
      },
      {
        "rank": 2,
        "feature_name": "spread1",
        "feature_value": -0.1295375398796535,
        "shap_value": 0.04052700474858284,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "PPE",
        "feature_value": -0.11143474730461202,
        "shap_value": 0.039738141000270844,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 4,
        "feature_name": "DFA",
        "feature_value": 0.3417950403522445,
        "shap_value": 0.034477267414331436,
        "contribution": "increases",
        "clinical_name": "Detrended Fluctuation Analysis",
        "normal_range": "0.6-0.7",
        "pd_indication": "Abnormal DFA indicates disrupted vocal control dynamics"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Flo(Hz)",
        "feature_value": -0.8480282241295909,
        "shap_value": 0.03358971327543259,
        "contribution": "increases",
        "clinical_name": "Minimum Vocal Frequency",
        "normal_range": "65-239 Hz",
        "pd_indication": "Narrowed frequency range indicates motor impairment"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 0.30664229031274937,
      "MDVP:Fhi(Hz)": 0.020393932963514824,
      "MDVP:Flo(Hz)": -0.8480282241295909,
      "MDVP:Jitter(%)": 0.03299189435978035,
      "MDVP:Jitter(Abs)": -0.11398469945008191,
      "MDVP:RAP": 0.12620614427342317,
      "MDVP:PPQ": 0.023126269715238283,
      "Jitter:DDP": 0.12612499941828667,
      "MDVP:Shimmer": -0.060564482995090894,
      "MDVP:Shimmer(dB)": -0.1299088211660579,
      "Shimmer:APQ3": -0.01917172278264325,
      "Shimmer:APQ5": 0.05934739671618153,
      "MDVP:APQ": -0.06338950339160032,
      "Shimmer:DDA": -0.019177016653893993,
      "NHR": -0.17083298723233387,
      "HNR": -0.805539392639946,
      "RPDE": 0.8356265565439853,
      "DFA": 0.3417950403522445,
      "spread1": -0.1295375398796535,
      "spread2": -1.3320252647322475,
      "D2": -1.010119627641985,
      "PPE": -0.11143474730461202
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.02701946720480919,
      "MDVP:Fhi(Hz)": 0.006425732746720314,
      "MDVP:Flo(Hz)": 0.03358971327543259,
      "MDVP:Jitter(%)": -0.007785760797560215,
      "MDVP:Jitter(Abs)": -0.012762132100760937,
      "MDVP:RAP": 0.03181919828057289,
      "MDVP:PPQ": -0.01293060090392828,
      "Jitter:DDP": 0.017621733248233795,
      "MDVP:Shimmer": -0.0017414179164916277,
      "MDVP:Shimmer(dB)": 0.008182577788829803,
      "Shimmer:APQ3": -0.004309931769967079,
      "Shimmer:APQ5": 0.0005581926670856774,
      "MDVP:APQ": 0.007424633949995041,
      "Shimmer:DDA": 0.00022384409385267645,
      "NHR": -0.001718404470011592,
      "HNR": 0.08642543852329254,
      "RPDE": -0.0007386180222965777,
      "DFA": 0.034477267414331436,
      "spread1": 0.04052700474858284,
      "spread2": -0.028769059106707573,
      "D2": 0.003333328990265727,
      "PPE": 0.039738141000270844
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_29\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 99.7%\n\nTOP CONTRIBUTING FEATURES:\n\n1. Harmonics-to-Noise Ratio (HNR)\n   Patient Value: -0.8055\n   Normal Range: >13 dB\n   SHAP Impact: 0.0864 (\u2191 increases PD probability)\n   Clinical Significance: Reduced HNR indicates increased vocal noise and hoarseness\n\n2. spread1 (spread1)\n   Patient Value: -0.1295\n   Normal Range: Not specified\n   SHAP Impact: 0.0405 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Pitch Period Entropy (PPE)\n   Patient Value: -0.1114\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0397 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n4. Detrended Fluctuation Analysis (DFA)\n   Patient Value: 0.3418\n   Normal Range: 0.6-0.7\n   SHAP Impact: 0.0345 (\u2191 increases PD probability)\n   Clinical Significance: Abnormal DFA indicates disrupted vocal control dynamics\n\n5. Minimum Vocal Frequency (MDVP:Flo(Hz))\n   Patient Value: -0.8480\n   Normal Range: 65-239 Hz\n   SHAP Impact: 0.0336 (\u2191 increases PD probability)\n   Clinical Significance: Narrowed frequency range indicates motor impairment\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_30",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.125029"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9989643096923828,
      "confidence": 0.9989643096923828,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.2687937595655967,
      "mean_abs_shap": 0.020075759355511928,
      "features_increasing_pd": 12,
      "features_decreasing_pd": 10
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": 0.5621918103835684,
        "shap_value": 0.11281244456768036,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "D2",
        "feature_value": 0.6782632052928604,
        "shap_value": 0.07432720810174942,
        "contribution": "increases",
        "clinical_name": "D2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "MDVP:Fhi(Hz)",
        "feature_value": 2.689689744555162,
        "shap_value": -0.06973282247781754,
        "contribution": "decreases",
        "clinical_name": "Maximum Vocal Frequency",
        "normal_range": "102-592 Hz",
        "pd_indication": "Reduced range suggests limited vocal control"
      },
      {
        "rank": 4,
        "feature_name": "MDVP:Flo(Hz)",
        "feature_value": -1.0222750886779859,
        "shap_value": 0.04413784667849541,
        "contribution": "increases",
        "clinical_name": "Minimum Vocal Frequency",
        "normal_range": "65-239 Hz",
        "pd_indication": "Narrowed frequency range indicates motor impairment"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Fo(Hz)",
        "feature_value": 0.09665677524002961,
        "shap_value": 0.031210100278258324,
        "contribution": "increases",
        "clinical_name": "Fundamental Frequency",
        "normal_range": "85-180 Hz (male), 165-255 Hz (female)",
        "pd_indication": "Reduced variability indicates vocal rigidity"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 0.09665677524002961,
      "MDVP:Fhi(Hz)": 2.689689744555162,
      "MDVP:Flo(Hz)": -1.0222750886779859,
      "MDVP:Jitter(%)": -0.3020174090235238,
      "MDVP:Jitter(Abs)": -0.4018994195636312,
      "MDVP:RAP": -0.39403689107742124,
      "MDVP:PPQ": -0.5001498411662191,
      "Jitter:DDP": -0.39411680258681586,
      "MDVP:Shimmer": -0.8043763851909161,
      "MDVP:Shimmer(dB)": -0.6906748637908667,
      "Shimmer:APQ3": -0.9483622330840518,
      "Shimmer:APQ5": -0.8678728283675253,
      "MDVP:APQ": -0.6484848741481359,
      "Shimmer:DDA": -0.9483786725573129,
      "NHR": -0.23086075136503756,
      "HNR": 1.0126005916969973,
      "RPDE": -0.46045435763630055,
      "DFA": -1.1645527451590143,
      "spread1": -0.3373489968358936,
      "spread2": 0.5621918103835684,
      "D2": 0.6782632052928604,
      "PPE": -0.40545635883831577
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.031210100278258324,
      "MDVP:Fhi(Hz)": -0.06973282247781754,
      "MDVP:Flo(Hz)": 0.04413784667849541,
      "MDVP:Jitter(%)": -0.003361671231687069,
      "MDVP:Jitter(Abs)": -0.00628953892737627,
      "MDVP:RAP": 0.0011574702803045511,
      "MDVP:PPQ": -0.0009163197828456759,
      "Jitter:DDP": -0.00023731653345748782,
      "MDVP:Shimmer": 0.0026443134993314743,
      "MDVP:Shimmer(dB)": -0.0012848211918026209,
      "Shimmer:APQ3": 0.009349377825856209,
      "Shimmer:APQ5": 0.00010637914965627715,
      "MDVP:APQ": -0.000578599632717669,
      "Shimmer:DDA": 0.01639539934694767,
      "NHR": -3.862934318021871e-05,
      "HNR": -0.0030717090703547,
      "RPDE": -0.000925044936593622,
      "DFA": 0.01984572783112526,
      "spread1": 0.02317401021718979,
      "spread2": 0.11281244456768036,
      "D2": 0.07432720810174942,
      "PPE": 0.02006995491683483
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_30\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 99.9%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: 0.5622\n   Normal Range: Not specified\n   SHAP Impact: 0.1128 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. D2 (D2)\n   Patient Value: 0.6783\n   Normal Range: Not specified\n   SHAP Impact: 0.0743 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Maximum Vocal Frequency (MDVP:Fhi(Hz))\n   Patient Value: 2.6897\n   Normal Range: 102-592 Hz\n   SHAP Impact: -0.0697 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced range suggests limited vocal control\n\n4. Minimum Vocal Frequency (MDVP:Flo(Hz))\n   Patient Value: -1.0223\n   Normal Range: 65-239 Hz\n   SHAP Impact: 0.0441 (\u2191 increases PD probability)\n   Clinical Significance: Narrowed frequency range indicates motor impairment\n\n5. Fundamental Frequency (MDVP:Fo(Hz))\n   Patient Value: 0.0967\n   Normal Range: 85-180 Hz (male), 165-255 Hz (female)\n   SHAP Impact: 0.0312 (\u2191 increases PD probability)\n   Clinical Significance: Reduced variability indicates vocal rigidity\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_31",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.125439"
    },
    "prediction": {
      "class": "Healthy",
      "probability": 0.031433288007974625,
      "confidence": 0.9685667157173157,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": -0.6987373732263222,
      "mean_abs_shap": 0.06177980666027658,
      "features_increasing_pd": 9,
      "features_decreasing_pd": 13
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": -1.9174567783432686,
        "shap_value": -0.3695073425769806,
        "contribution": "decreases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "MDVP:Fo(Hz)",
        "feature_value": 1.330191479943945,
        "shap_value": -0.13083043694496155,
        "contribution": "decreases",
        "clinical_name": "Fundamental Frequency",
        "normal_range": "85-180 Hz (male), 165-255 Hz (female)",
        "pd_indication": "Reduced variability indicates vocal rigidity"
      },
      {
        "rank": 3,
        "feature_name": "PPE",
        "feature_value": -1.1685174786346288,
        "shap_value": -0.12867359817028046,
        "contribution": "decreases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 4,
        "feature_name": "spread1",
        "feature_value": -1.247103479968546,
        "shap_value": -0.122373066842556,
        "contribution": "decreases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 5,
        "feature_name": "RPDE",
        "feature_value": -1.5119147207711503,
        "shap_value": 0.10625559836626053,
        "contribution": "increases",
        "clinical_name": "Recurrence Period Density Entropy",
        "normal_range": "0.4-0.7",
        "pd_indication": "Altered RPDE reflects changes in vocal signal complexity"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 1.330191479943945,
      "MDVP:Fhi(Hz)": 0.4425878113457332,
      "MDVP:Flo(Hz)": -0.16000190161942304,
      "MDVP:Jitter(%)": -0.703201389618345,
      "MDVP:Jitter(Abs)": -0.9777288597907295,
      "MDVP:RAP": -0.620376393470321,
      "MDVP:PPQ": -0.7000122446278867,
      "Jitter:DDP": -0.6193297038877261,
      "MDVP:Shimmer": -0.5901117700480157,
      "MDVP:Shimmer(dB)": -0.5774927267473272,
      "Shimmer:APQ3": -0.583993159437697,
      "Shimmer:APQ5": -0.4417851170206062,
      "MDVP:APQ": -0.6070726638822537,
      "Shimmer:DDA": -0.584005228318884,
      "NHR": -0.4002779534420484,
      "HNR": 0.8309225120261484,
      "RPDE": -1.5119147207711503,
      "DFA": -0.7106789840201961,
      "spread1": -1.247103479968546,
      "spread2": -1.9174567783432686,
      "D2": 0.20681391387965914,
      "PPE": -1.1685174786346288
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": -0.13083043694496155,
      "MDVP:Fhi(Hz)": -0.07661137729883194,
      "MDVP:Flo(Hz)": -0.010075710713863373,
      "MDVP:Jitter(%)": 0.021923763677477837,
      "MDVP:Jitter(Abs)": 0.0877799540758133,
      "MDVP:RAP": -0.0315011665225029,
      "MDVP:PPQ": 0.04613225534558296,
      "Jitter:DDP": 0.002069903304800391,
      "MDVP:Shimmer": -0.009055615402758121,
      "MDVP:Shimmer(dB)": -0.025940455496311188,
      "Shimmer:APQ3": 0.0010789657244458795,
      "Shimmer:APQ5": -0.013896512798964977,
      "MDVP:APQ": -0.03413594141602516,
      "Shimmer:DDA": 0.0177580788731575,
      "NHR": 0.012100320309400558,
      "HNR": -0.057442959398031235,
      "RPDE": 0.10625559836626053,
      "DFA": -0.018902376294136047,
      "spread1": -0.122373066842556,
      "spread2": -0.3695073425769806,
      "D2": 0.03511034697294235,
      "PPE": -0.12867359817028046
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_31\nPREDICTION: Healthy\nCONFIDENCE: 96.9%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: -1.9175\n   Normal Range: Not specified\n   SHAP Impact: -0.3695 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. Fundamental Frequency (MDVP:Fo(Hz))\n   Patient Value: 1.3302\n   Normal Range: 85-180 Hz (male), 165-255 Hz (female)\n   SHAP Impact: -0.1308 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced variability indicates vocal rigidity\n\n3. Pitch Period Entropy (PPE)\n   Patient Value: -1.1685\n   Normal Range: 0.1-0.3\n   SHAP Impact: -0.1287 (\u2193 decreases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n4. spread1 (spread1)\n   Patient Value: -1.2471\n   Normal Range: Not specified\n   SHAP Impact: -0.1224 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n5. Recurrence Period Density Entropy (RPDE)\n   Patient Value: -1.5119\n   Normal Range: 0.4-0.7\n   SHAP Impact: 0.1063 (\u2191 increases PD probability)\n   Clinical Significance: Altered RPDE reflects changes in vocal signal complexity\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_32",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.125879"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9679248929023743,
      "confidence": 0.9679248929023743,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.23775428353110328,
      "mean_abs_shap": 0.017967173276701942,
      "features_increasing_pd": 12,
      "features_decreasing_pd": 10
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "MDVP:Fhi(Hz)",
        "feature_value": -1.0388274768761763,
        "shap_value": 0.07264354825019836,
        "contribution": "increases",
        "clinical_name": "Maximum Vocal Frequency",
        "normal_range": "102-592 Hz",
        "pd_indication": "Reduced range suggests limited vocal control"
      },
      {
        "rank": 2,
        "feature_name": "DFA",
        "feature_value": 0.9841140128440989,
        "shap_value": 0.060817040503025055,
        "contribution": "increases",
        "clinical_name": "Detrended Fluctuation Analysis",
        "normal_range": "0.6-0.7",
        "pd_indication": "Abnormal DFA indicates disrupted vocal control dynamics"
      },
      {
        "rank": 3,
        "feature_name": "HNR",
        "feature_value": 0.08110400365893214,
        "shap_value": 0.04518158733844757,
        "contribution": "increases",
        "clinical_name": "Harmonics-to-Noise Ratio",
        "normal_range": ">13 dB",
        "pd_indication": "Reduced HNR indicates increased vocal noise and hoarseness"
      },
      {
        "rank": 4,
        "feature_name": "spread1",
        "feature_value": -0.3135621736970202,
        "shap_value": 0.03444408252835274,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 5,
        "feature_name": "PPE",
        "feature_value": -0.32570150874617765,
        "shap_value": 0.0312056727707386,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -1.342527603355613,
      "MDVP:Fhi(Hz)": -1.0388274768761763,
      "MDVP:Flo(Hz)": -0.6570109051402612,
      "MDVP:Jitter(%)": -0.3930075901893596,
      "MDVP:Jitter(Abs)": -0.11398469945008191,
      "MDVP:RAP": -0.28255624064509743,
      "MDVP:PPQ": -0.3148228852290363,
      "Jitter:DDP": -0.28151035193636076,
      "MDVP:Shimmer": -0.3976457882074949,
      "MDVP:Shimmer(dB)": -0.4128641637749063,
      "Shimmer:APQ3": -0.28578324008485395,
      "Shimmer:APQ5": -0.3709094703190638,
      "MDVP:APQ": -0.5065001532365397,
      "Shimmer:DDA": -0.2857917319503055,
      "NHR": -0.3975494187087437,
      "HNR": 0.08110400365893214,
      "RPDE": 0.753398324310937,
      "DFA": 0.9841140128440989,
      "spread1": -0.3135621736970202,
      "spread2": -1.7827316812331866,
      "D2": -0.8596414849133942,
      "PPE": -0.32570150874617765
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.012959148734807968,
      "MDVP:Fhi(Hz)": 0.07264354825019836,
      "MDVP:Flo(Hz)": 0.029724841937422752,
      "MDVP:Jitter(%)": -0.002466377103701234,
      "MDVP:Jitter(Abs)": -0.021105408668518066,
      "MDVP:RAP": 0.013896347023546696,
      "MDVP:PPQ": -0.005957393441349268,
      "Jitter:DDP": 0.010589104145765305,
      "MDVP:Shimmer": -0.0034442604519426823,
      "MDVP:Shimmer(dB)": 0.001838794443756342,
      "Shimmer:APQ3": -0.0034571154974400997,
      "Shimmer:APQ5": -0.00457204831764102,
      "MDVP:APQ": -0.0004851247067563236,
      "Shimmer:DDA": 0.0018030728679150343,
      "NHR": 0.0014128072652965784,
      "HNR": 0.04518158733844757,
      "RPDE": -0.014790293760597706,
      "DFA": 0.060817040503025055,
      "spread1": 0.03444408252835274,
      "spread2": -0.01743299514055252,
      "D2": -0.005050747189670801,
      "PPE": 0.0312056727707386
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_32\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 96.8%\n\nTOP CONTRIBUTING FEATURES:\n\n1. Maximum Vocal Frequency (MDVP:Fhi(Hz))\n   Patient Value: -1.0388\n   Normal Range: 102-592 Hz\n   SHAP Impact: 0.0726 (\u2191 increases PD probability)\n   Clinical Significance: Reduced range suggests limited vocal control\n\n2. Detrended Fluctuation Analysis (DFA)\n   Patient Value: 0.9841\n   Normal Range: 0.6-0.7\n   SHAP Impact: 0.0608 (\u2191 increases PD probability)\n   Clinical Significance: Abnormal DFA indicates disrupted vocal control dynamics\n\n3. Harmonics-to-Noise Ratio (HNR)\n   Patient Value: 0.0811\n   Normal Range: >13 dB\n   SHAP Impact: 0.0452 (\u2191 increases PD probability)\n   Clinical Significance: Reduced HNR indicates increased vocal noise and hoarseness\n\n4. spread1 (spread1)\n   Patient Value: -0.3136\n   Normal Range: Not specified\n   SHAP Impact: 0.0344 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n5. Pitch Period Entropy (PPE)\n   Patient Value: -0.3257\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0312 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_33",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.126277"
    },
    "prediction": {
      "class": "Healthy",
      "probability": 0.05272718891501427,
      "confidence": 0.9472728371620178,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": -0.6774433831451461,
      "mean_abs_shap": 0.040828060194722966,
      "features_increasing_pd": 6,
      "features_decreasing_pd": 16
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "HNR",
        "feature_value": 1.1340213531727756,
        "shap_value": -0.12904004752635956,
        "contribution": "decreases",
        "clinical_name": "Harmonics-to-Noise Ratio",
        "normal_range": ">13 dB",
        "pd_indication": "Reduced HNR indicates increased vocal noise and hoarseness"
      },
      {
        "rank": 2,
        "feature_name": "MDVP:RAP",
        "feature_value": -0.6305109980550777,
        "shap_value": -0.07528533786535263,
        "contribution": "decreases",
        "clinical_name": "MDVP:RAP",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "PPE",
        "feature_value": -0.4761109902980968,
        "shap_value": -0.06839257478713989,
        "contribution": "decreases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 4,
        "feature_name": "spread2",
        "feature_value": -0.5143468202447188,
        "shap_value": -0.06274925172328949,
        "contribution": "decreases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 5,
        "feature_name": "RPDE",
        "feature_value": 1.339615689964396,
        "shap_value": -0.06233148276805878,
        "contribution": "decreases",
        "clinical_name": "Recurrence Period Density Entropy",
        "normal_range": "0.4-0.7",
        "pd_indication": "Altered RPDE reflects changes in vocal signal complexity"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -1.1359574715595409,
      "MDVP:Fhi(Hz)": -0.9124257330239419,
      "MDVP:Flo(Hz)": -0.2766579198733988,
      "MDVP:Jitter(%)": -0.6866577203154658,
      "MDVP:Jitter(Abs)": -0.4018994195636312,
      "MDVP:RAP": -0.6305109980550777,
      "MDVP:PPQ": -0.5909963881942497,
      "Jitter:DDP": -0.6317164134592762,
      "MDVP:Shimmer": -0.7464239210455659,
      "MDVP:Shimmer(dB)": -0.7626998600913008,
      "Shimmer:APQ3": -0.7281608687937072,
      "Shimmer:APQ5": -0.7019404319721498,
      "MDVP:APQ": -0.6816146423608417,
      "Shimmer:DDA": -0.7281746669606473,
      "NHR": -0.530999572028556,
      "HNR": 1.1340213531727756,
      "RPDE": 1.339615689964396,
      "DFA": 0.8182619347049128,
      "spread1": -0.4443648712915774,
      "spread2": -0.5143468202447188,
      "D2": -0.8305908616578803,
      "PPE": -0.4761109902980968
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": -0.033064067363739014,
      "MDVP:Fhi(Hz)": 0.05218495801091194,
      "MDVP:Flo(Hz)": -0.01455769408494234,
      "MDVP:Jitter(%)": 0.01363880280405283,
      "MDVP:Jitter(Abs)": 0.0014970359625294805,
      "MDVP:RAP": -0.07528533786535263,
      "MDVP:PPQ": 0.008299343287944794,
      "Jitter:DDP": -0.04914339631795883,
      "MDVP:Shimmer": -0.04088124632835388,
      "MDVP:Shimmer(dB)": -0.04685062915086746,
      "Shimmer:APQ3": -0.03275362402200699,
      "Shimmer:APQ5": -0.02590152807533741,
      "MDVP:APQ": -0.018920568749308586,
      "Shimmer:DDA": -0.03275821730494499,
      "NHR": 0.01346932165324688,
      "HNR": -0.12904004752635956,
      "RPDE": -0.06233148276805878,
      "DFA": 0.021297508850693703,
      "spread1": -0.04198542609810829,
      "spread2": -0.06274925172328949,
      "D2": -0.05321526154875755,
      "PPE": -0.06839257478713989
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_33\nPREDICTION: Healthy\nCONFIDENCE: 94.7%\n\nTOP CONTRIBUTING FEATURES:\n\n1. Harmonics-to-Noise Ratio (HNR)\n   Patient Value: 1.1340\n   Normal Range: >13 dB\n   SHAP Impact: -0.1290 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced HNR indicates increased vocal noise and hoarseness\n\n2. MDVP:RAP (MDVP:RAP)\n   Patient Value: -0.6305\n   Normal Range: Not specified\n   SHAP Impact: -0.0753 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Pitch Period Entropy (PPE)\n   Patient Value: -0.4761\n   Normal Range: 0.1-0.3\n   SHAP Impact: -0.0684 (\u2193 decreases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n4. spread2 (spread2)\n   Patient Value: -0.5143\n   Normal Range: Not specified\n   SHAP Impact: -0.0627 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n5. Recurrence Period Density Entropy (RPDE)\n   Patient Value: 1.3396\n   Normal Range: 0.4-0.7\n   SHAP Impact: -0.0623 (\u2193 decreases PD probability)\n   Clinical Significance: Altered RPDE reflects changes in vocal signal complexity\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_34",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.126656"
    },
    "prediction": {
      "class": "Healthy",
      "probability": 0.0004706487525254488,
      "confidence": 0.9995293617248535,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": -0.7296999078243971,
      "mean_abs_shap": 0.04085228476800363,
      "features_increasing_pd": 6,
      "features_decreasing_pd": 16
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": -1.8416799214390969,
        "shap_value": -0.20814815163612366,
        "contribution": "decreases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "MDVP:Fo(Hz)",
        "feature_value": 2.0848942937772263,
        "shap_value": -0.12049191445112228,
        "contribution": "decreases",
        "clinical_name": "Fundamental Frequency",
        "normal_range": "85-180 Hz (male), 165-255 Hz (female)",
        "pd_indication": "Reduced variability indicates vocal rigidity"
      },
      {
        "rank": 3,
        "feature_name": "spread1",
        "feature_value": -1.3659116080819187,
        "shap_value": -0.11611580103635788,
        "contribution": "decreases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 4,
        "feature_name": "PPE",
        "feature_value": -1.1755818292844415,
        "shap_value": -0.10524704307317734,
        "contribution": "decreases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 5,
        "feature_name": "DFA",
        "feature_value": -1.3032640746579884,
        "shap_value": -0.07707974314689636,
        "contribution": "decreases",
        "clinical_name": "Detrended Fluctuation Analysis",
        "normal_range": "0.6-0.7",
        "pd_indication": "Abnormal DFA indicates disrupted vocal control dynamics"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 2.0848942937772263,
      "MDVP:Fhi(Hz)": 0.5263186934241834,
      "MDVP:Flo(Hz)": 2.3833020160962013,
      "MDVP:Jitter(%)": -0.21723110384626787,
      "MDVP:Jitter(Abs)": -0.6898141396771803,
      "MDVP:RAP": -0.049460335195693116,
      "MDVP:PPQ": -0.22397633820100543,
      "Jitter:DDP": -0.04841499908991868,
      "MDVP:Shimmer": -0.5066389547193921,
      "MDVP:Shimmer(dB)": -0.3614177378460249,
      "Shimmer:APQ3": -0.38551569655716245,
      "Shimmer:APQ5": -0.49765180324417474,
      "MDVP:APQ": -0.6295535780265897,
      "Shimmer:DDA": -0.3851962307398315,
      "NHR": -0.376961383902899,
      "HNR": -0.19617027254695102,
      "RPDE": -1.2220758761528667,
      "DFA": -1.3032640746579884,
      "spread1": -1.3659116080819187,
      "spread2": -1.8416799214390969,
      "D2": -0.30222413925037606,
      "PPE": -1.1755818292844415
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": -0.12049191445112228,
      "MDVP:Fhi(Hz)": -0.06705405563116074,
      "MDVP:Flo(Hz)": 0.007559599354863167,
      "MDVP:Jitter(%)": -0.001513014081865549,
      "MDVP:Jitter(Abs)": 0.026095081120729446,
      "MDVP:RAP": -0.00991667527705431,
      "MDVP:PPQ": -0.0011478959349915385,
      "Jitter:DDP": -0.00897627416998148,
      "MDVP:Shimmer": -0.013667314313352108,
      "MDVP:Shimmer(dB)": -0.021171754226088524,
      "Shimmer:APQ3": -0.010954184457659721,
      "Shimmer:APQ5": -0.0103156054392457,
      "MDVP:APQ": -0.02943265624344349,
      "Shimmer:DDA": 0.0015406683087348938,
      "NHR": 0.011884024366736412,
      "HNR": 0.0006540262838825583,
      "RPDE": 0.03679177910089493,
      "DFA": -0.07707974314689636,
      "spread1": -0.11611580103635788,
      "spread2": -0.20814815163612366,
      "D2": -0.012993003241717815,
      "PPE": -0.10524704307317734
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_34\nPREDICTION: Healthy\nCONFIDENCE: 100.0%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: -1.8417\n   Normal Range: Not specified\n   SHAP Impact: -0.2081 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. Fundamental Frequency (MDVP:Fo(Hz))\n   Patient Value: 2.0849\n   Normal Range: 85-180 Hz (male), 165-255 Hz (female)\n   SHAP Impact: -0.1205 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced variability indicates vocal rigidity\n\n3. spread1 (spread1)\n   Patient Value: -1.3659\n   Normal Range: Not specified\n   SHAP Impact: -0.1161 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n4. Pitch Period Entropy (PPE)\n   Patient Value: -1.1756\n   Normal Range: 0.1-0.3\n   SHAP Impact: -0.1052 (\u2193 decreases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n5. Detrended Fluctuation Analysis (DFA)\n   Patient Value: -1.3033\n   Normal Range: 0.6-0.7\n   SHAP Impact: -0.0771 (\u2193 decreases PD probability)\n   Clinical Significance: Abnormal DFA indicates disrupted vocal control dynamics\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_35",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.127223"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9911258816719055,
      "confidence": 0.9911258816719055,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.26095531129976735,
      "mean_abs_shap": 0.022703765259145504,
      "features_increasing_pd": 11,
      "features_decreasing_pd": 11
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread1",
        "feature_value": 0.7533530803622241,
        "shap_value": 0.09845831990242004,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "spread2",
        "feature_value": 0.2391304515389425,
        "shap_value": 0.0524471141397953,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "MDVP:Jitter(Abs)",
        "feature_value": 0.4618447407770164,
        "shap_value": -0.04898682236671448,
        "contribution": "decreases",
        "clinical_name": "Absolute Jitter",
        "normal_range": "<83 microseconds",
        "pd_indication": "Increased jitter reflects neuromuscular instability"
      },
      {
        "rank": 4,
        "feature_name": "MDVP:RAP",
        "feature_value": 0.19377017483846792,
        "shap_value": 0.04438682645559311,
        "contribution": "increases",
        "clinical_name": "MDVP:RAP",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Fhi(Hz)",
        "feature_value": -0.6296627856149207,
        "shap_value": 0.039700061082839966,
        "contribution": "increases",
        "clinical_name": "Maximum Vocal Frequency",
        "normal_range": "102-592 Hz",
        "pd_indication": "Reduced range suggests limited vocal control"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -0.7965265080442543,
      "MDVP:Fhi(Hz)": -0.6296627856149207,
      "MDVP:Flo(Hz)": -0.4163733129836598,
      "MDVP:Jitter(%)": 0.12811799285133577,
      "MDVP:Jitter(Abs)": 0.4618447407770164,
      "MDVP:RAP": 0.19377017483846792,
      "MDVP:PPQ": -0.04591710602606513,
      "Jitter:DDP": 0.19368886980855973,
      "MDVP:Shimmer": -0.23229517949920206,
      "MDVP:Shimmer(dB)": -0.21222310265226843,
      "Shimmer:APQ3": -0.2235738860476714,
      "Shimmer:APQ5": -0.32421492660981227,
      "MDVP:APQ": -0.20833223932218806,
      "Shimmer:DDA": -0.2239107856839779,
      "NHR": 0.4202668554463144,
      "HNR": -0.0829046368419334,
      "RPDE": 0.6590938754496448,
      "DFA": -0.8628519799007962,
      "spread1": 0.7533530803622241,
      "spread2": 0.2391304515389425,
      "D2": -0.9645898733439466,
      "PPE": -0.42242192535951967
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.027305755764245987,
      "MDVP:Fhi(Hz)": 0.039700061082839966,
      "MDVP:Flo(Hz)": 0.02693251520395279,
      "MDVP:Jitter(%)": -0.008646788075566292,
      "MDVP:Jitter(Abs)": -0.04898682236671448,
      "MDVP:RAP": 0.04438682645559311,
      "MDVP:PPQ": -0.014507513493299484,
      "Jitter:DDP": 0.030862001702189445,
      "MDVP:Shimmer": -0.001279972493648529,
      "MDVP:Shimmer(dB)": 0.0043266876600682735,
      "Shimmer:APQ3": -0.005132871679961681,
      "Shimmer:APQ5": -0.0006512945401482284,
      "MDVP:APQ": 0.003924988210201263,
      "Shimmer:DDA": -0.0016080461209639907,
      "NHR": -0.004450433887541294,
      "HNR": 0.03112068586051464,
      "RPDE": -0.022927729412913322,
      "DFA": -0.005574596580117941,
      "spread1": 0.09845831990242004,
      "spread2": 0.0524471141397953,
      "D2": -0.005497693549841642,
      "PPE": 0.020754117518663406
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_35\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 99.1%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread1 (spread1)\n   Patient Value: 0.7534\n   Normal Range: Not specified\n   SHAP Impact: 0.0985 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. spread2 (spread2)\n   Patient Value: 0.2391\n   Normal Range: Not specified\n   SHAP Impact: 0.0524 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Absolute Jitter (MDVP:Jitter(Abs))\n   Patient Value: 0.4618\n   Normal Range: <83 microseconds\n   SHAP Impact: -0.0490 (\u2193 decreases PD probability)\n   Clinical Significance: Increased jitter reflects neuromuscular instability\n\n4. MDVP:RAP (MDVP:RAP)\n   Patient Value: 0.1938\n   Normal Range: Not specified\n   SHAP Impact: 0.0444 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n5. Maximum Vocal Frequency (MDVP:Fhi(Hz))\n   Patient Value: -0.6297\n   Normal Range: 102-592 Hz\n   SHAP Impact: 0.0397 (\u2191 increases PD probability)\n   Clinical Significance: Reduced range suggests limited vocal control\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_36",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.127606"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9999501705169678,
      "confidence": 0.9999501705169678,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.26977957009512465,
      "mean_abs_shap": 0.017879789459005802,
      "features_increasing_pd": 15,
      "features_decreasing_pd": 7
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": 1.3131447896624902,
        "shap_value": 0.11449810862541199,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "HNR",
        "feature_value": -1.3505736316524906,
        "shap_value": 0.07436959445476532,
        "contribution": "increases",
        "clinical_name": "Harmonics-to-Noise Ratio",
        "normal_range": ">13 dB",
        "pd_indication": "Reduced HNR indicates increased vocal noise and hoarseness"
      },
      {
        "rank": 3,
        "feature_name": "D2",
        "feature_value": 0.7135498124981913,
        "shap_value": 0.054752107709646225,
        "contribution": "increases",
        "clinical_name": "D2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 4,
        "feature_name": "RPDE",
        "feature_value": 0.9662754017752619,
        "shap_value": -0.027827883139252663,
        "contribution": "decreases",
        "clinical_name": "Recurrence Period Density Entropy",
        "normal_range": "0.4-0.7",
        "pd_indication": "Altered RPDE reflects changes in vocal signal complexity"
      },
      {
        "rank": 5,
        "feature_name": "Shimmer:DDA",
        "feature_value": 0.5002279472198556,
        "shap_value": -0.021285243332386017,
        "contribution": "decreases",
        "clinical_name": "Shimmer:DDA",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 0.5811809715717415,
      "MDVP:Fhi(Hz)": 0.05857197159213923,
      "MDVP:Flo(Hz)": 0.5695128665612441,
      "MDVP:Jitter(%)": -0.6225510017668088,
      "MDVP:Jitter(Abs)": -0.6898141396771803,
      "MDVP:RAP": -0.5663251690182852,
      "MDVP:PPQ": -0.547390045620795,
      "Jitter:DDP": -0.5675307365885168,
      "MDVP:Shimmer": 0.4190054496572565,
      "MDVP:Shimmer(dB)": 0.23021616033611286,
      "Shimmer:APQ3": 0.5002270109246265,
      "Shimmer:APQ5": 0.5229575092580353,
      "MDVP:APQ": 0.22235474744298692,
      "Shimmer:DDA": 0.5002279472198556,
      "NHR": 0.16527288218838312,
      "HNR": -1.3505736316524906,
      "RPDE": 0.9662754017752619,
      "DFA": -0.10689697571908317,
      "spread1": -0.6276565700574599,
      "spread2": 1.3131447896624902,
      "D2": 0.7135498124981913,
      "PPE": -0.6890538813029261
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.017433159053325653,
      "MDVP:Fhi(Hz)": 0.00476480508223176,
      "MDVP:Flo(Hz)": -0.0032522163819521666,
      "MDVP:Jitter(%)": 0.0026708173099905252,
      "MDVP:Jitter(Abs)": 0.008616359904408455,
      "MDVP:RAP": -0.0012582315830513835,
      "MDVP:PPQ": 0.00029359397012740374,
      "Jitter:DDP": 0.0007095637265592813,
      "MDVP:Shimmer": -0.0017372091533616185,
      "MDVP:Shimmer(dB)": 0.00988276582211256,
      "Shimmer:APQ3": -0.001803476014174521,
      "Shimmer:APQ5": 7.138393993955106e-05,
      "MDVP:APQ": 0.017527393996715546,
      "Shimmer:DDA": -0.021285243332386017,
      "NHR": -0.0046236393973231316,
      "HNR": 0.07436959445476532,
      "RPDE": -0.027827883139252663,
      "DFA": 0.0047823600471019745,
      "spread1": 0.013122263364493847,
      "spread2": 0.11449810862541199,
      "D2": 0.054752107709646225,
      "PPE": 0.008073192089796066
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_36\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 100.0%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: 1.3131\n   Normal Range: Not specified\n   SHAP Impact: 0.1145 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. Harmonics-to-Noise Ratio (HNR)\n   Patient Value: -1.3506\n   Normal Range: >13 dB\n   SHAP Impact: 0.0744 (\u2191 increases PD probability)\n   Clinical Significance: Reduced HNR indicates increased vocal noise and hoarseness\n\n3. D2 (D2)\n   Patient Value: 0.7135\n   Normal Range: Not specified\n   SHAP Impact: 0.0548 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n4. Recurrence Period Density Entropy (RPDE)\n   Patient Value: 0.9663\n   Normal Range: 0.4-0.7\n   SHAP Impact: -0.0278 (\u2193 decreases PD probability)\n   Clinical Significance: Altered RPDE reflects changes in vocal signal complexity\n\n5. Shimmer:DDA (Shimmer:DDA)\n   Patient Value: 0.5002\n   Normal Range: Not specified\n   SHAP Impact: -0.0213 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_37",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.128027"
    },
    "prediction": {
      "class": "Parkinson's Disease",
      "probability": 0.9137290120124817,
      "confidence": 0.9137290120124817,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": 0.18355841338052414,
      "mean_abs_shap": 0.040167792767699044,
      "features_increasing_pd": 12,
      "features_decreasing_pd": 10
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": 0.9631456236601472,
        "shap_value": 0.20018960535526276,
        "contribution": "increases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "PPE",
        "feature_value": 0.21036589347725346,
        "shap_value": 0.09684500843286514,
        "contribution": "increases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 3,
        "feature_name": "spread1",
        "feature_value": 0.2715333486191739,
        "shap_value": 0.0934039056301117,
        "contribution": "increases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 4,
        "feature_name": "MDVP:Fhi(Hz)",
        "feature_value": 4.289145742337217,
        "shap_value": -0.0730239599943161,
        "contribution": "decreases",
        "clinical_name": "Maximum Vocal Frequency",
        "normal_range": "102-592 Hz",
        "pd_indication": "Reduced range suggests limited vocal control"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Jitter(Abs)",
        "feature_value": 0.17393002066346724,
        "shap_value": -0.07126948237419128,
        "contribution": "decreases",
        "clinical_name": "Absolute Jitter",
        "normal_range": "<83 microseconds",
        "pd_indication": "Increased jitter reflects neuromuscular instability"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": -1.0225473687137139,
      "MDVP:Fhi(Hz)": 4.289145742337217,
      "MDVP:Flo(Hz)": -0.21425247882876605,
      "MDVP:Jitter(%)": -0.18414376524050952,
      "MDVP:Jitter(Abs)": 0.17393002066346724,
      "MDVP:RAP": -0.21161400855180043,
      "MDVP:PPQ": -0.05681869166942884,
      "Jitter:DDP": -0.2105682880265741,
      "MDVP:Shimmer": -0.27801914203590056,
      "MDVP:Shimmer(dB)": -0.28939274154559064,
      "Shimmer:APQ3": -0.19098803393295685,
      "Shimmer:APQ5": -0.3442268739137772,
      "MDVP:APQ": -0.26749253970201964,
      "Shimmer:DDA": -0.19066623476430178,
      "NHR": -0.4617940092474637,
      "HNR": 0.5192154825659405,
      "RPDE": 0.10216037056563201,
      "DFA": 1.2942215253446794,
      "spread1": 0.2715333486191739,
      "spread2": 0.9631456236601472,
      "D2": -1.1867438551127132,
      "PPE": 0.21036589347725346
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": 0.05270317196846008,
      "MDVP:Fhi(Hz)": -0.0730239599943161,
      "MDVP:Flo(Hz)": 0.019347714260220528,
      "MDVP:Jitter(%)": -0.01211527083069086,
      "MDVP:Jitter(Abs)": -0.07126948237419128,
      "MDVP:RAP": 0.010360278189182281,
      "MDVP:PPQ": -0.03694393113255501,
      "Jitter:DDP": 0.004028023686259985,
      "MDVP:Shimmer": -0.013951093889772892,
      "MDVP:Shimmer(dB)": 0.005397700238972902,
      "Shimmer:APQ3": -0.020052528008818626,
      "Shimmer:APQ5": -0.008636020123958588,
      "MDVP:APQ": 0.007725710980594158,
      "Shimmer:DDA": -0.013785810209810734,
      "NHR": 0.00221730163320899,
      "HNR": 0.0004030895361211151,
      "RPDE": -0.03719611093401909,
      "DFA": 0.04100341722369194,
      "spread1": 0.0934039056301117,
      "spread2": 0.20018960535526276,
      "D2": -0.06309230625629425,
      "PPE": 0.09684500843286514
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_37\nPREDICTION: Parkinson's Disease\nCONFIDENCE: 91.4%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: 0.9631\n   Normal Range: Not specified\n   SHAP Impact: 0.2002 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. Pitch Period Entropy (PPE)\n   Patient Value: 0.2104\n   Normal Range: 0.1-0.3\n   SHAP Impact: 0.0968 (\u2191 increases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n3. spread1 (spread1)\n   Patient Value: 0.2715\n   Normal Range: Not specified\n   SHAP Impact: 0.0934 (\u2191 increases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n4. Maximum Vocal Frequency (MDVP:Fhi(Hz))\n   Patient Value: 4.2891\n   Normal Range: 102-592 Hz\n   SHAP Impact: -0.0730 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced range suggests limited vocal control\n\n5. Absolute Jitter (MDVP:Jitter(Abs))\n   Patient Value: 0.1739\n   Normal Range: <83 microseconds\n   SHAP Impact: -0.0713 (\u2193 decreases PD probability)\n   Clinical Significance: Increased jitter reflects neuromuscular instability\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  },
  {
    "metadata": {
      "patient_id": "patient_38",
      "model_version": "FNN_v1.0",
      "analysis_date": "2025-11-20T00:54:33.128421"
    },
    "prediction": {
      "class": "Healthy",
      "probability": 0.0006500552990473807,
      "confidence": 0.9993499517440796,
      "threshold": 0.5
    },
    "shap_analysis": {
      "total_shap_contribution": -0.7295204145048046,
      "mean_abs_shap": 0.060514086962608744,
      "features_increasing_pd": 8,
      "features_decreasing_pd": 14
    },
    "top_contributing_features": [
      {
        "rank": 1,
        "feature_name": "spread2",
        "feature_value": -2.0394642494056643,
        "shap_value": -0.2398824244737625,
        "contribution": "decreases",
        "clinical_name": "spread2",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 2,
        "feature_name": "spread1",
        "feature_value": -1.6662246183927507,
        "shap_value": -0.15860658884048462,
        "contribution": "decreases",
        "clinical_name": "spread1",
        "normal_range": "Not specified",
        "pd_indication": "Clinical interpretation not available"
      },
      {
        "rank": 3,
        "feature_name": "PPE",
        "feature_value": -1.479293282418125,
        "shap_value": -0.14074255526065826,
        "contribution": "decreases",
        "clinical_name": "Pitch Period Entropy",
        "normal_range": "0.1-0.3",
        "pd_indication": "Increased entropy indicates irregular vocal fold vibration"
      },
      {
        "rank": 4,
        "feature_name": "RPDE",
        "feature_value": -2.1382768257271256,
        "shap_value": 0.12584426999092102,
        "contribution": "increases",
        "clinical_name": "Recurrence Period Density Entropy",
        "normal_range": "0.4-0.7",
        "pd_indication": "Altered RPDE reflects changes in vocal signal complexity"
      },
      {
        "rank": 5,
        "feature_name": "MDVP:Fo(Hz)",
        "feature_value": 1.8208682106889074,
        "shap_value": -0.09684095531702042,
        "contribution": "decreases",
        "clinical_name": "Fundamental Frequency",
        "normal_range": "85-180 Hz (male), 165-255 Hz (female)",
        "pd_indication": "Reduced variability indicates vocal rigidity"
      }
    ],
    "all_feature_values": {
      "MDVP:Fo(Hz)": 1.8208682106889074,
      "MDVP:Fhi(Hz)": 0.6039678270988201,
      "MDVP:Flo(Hz)": 2.4149309088810966,
      "MDVP:Jitter(%)": -0.8624342066585573,
      "MDVP:Jitter(Abs)": -1.0065203318020843,
      "MDVP:RAP": -0.7318570439026448,
      "MDVP:PPQ": -0.8417328579916147,
      "Jitter:DDP": -0.7319361545381813,
      "MDVP:Shimmer": -0.804908059173901,
      "MDVP:Shimmer(dB)": -0.7884230730557416,
      "Shimmer:APQ3": -0.7874078726386432,
      "Shimmer:APQ5": -0.6927682894578325,
      "MDVP:APQ": -0.8235993632724378,
      "Shimmer:DDA": -0.7870932275014592,
      "NHR": -0.5419137109617749,
      "HNR": 1.0259659367101888,
      "RPDE": -2.1382768257271256,
      "DFA": -0.8055810143122052,
      "spread1": -1.6662246183927507,
      "spread2": -2.0394642494056643,
      "D2": -0.992084774438102,
      "PPE": -1.479293282418125
    },
    "all_shap_values": {
      "MDVP:Fo(Hz)": -0.09684095531702042,
      "MDVP:Fhi(Hz)": -0.06963545829057693,
      "MDVP:Flo(Hz)": -0.032750874757766724,
      "MDVP:Jitter(%)": 0.02658744528889656,
      "MDVP:Jitter(Abs)": 0.05827876552939415,
      "MDVP:RAP": -0.03152350336313248,
      "MDVP:PPQ": 0.041246447712183,
      "Jitter:DDP": -0.0021748337894678116,
      "MDVP:Shimmer": 3.754392673727125e-05,
      "MDVP:Shimmer(dB)": -0.02650933340191841,
      "Shimmer:APQ3": 0.007351922336965799,
      "Shimmer:APQ5": -0.0052678207866847515,
      "MDVP:APQ": -0.04344650357961655,
      "Shimmer:DDA": 0.024939723312854767,
      "NHR": 0.01660863123834133,
      "HNR": -0.0732414647936821,
      "RPDE": 0.12584426999092102,
      "DFA": -0.04020772501826286,
      "spread1": -0.15860658884048462,
      "spread2": -0.2398824244737625,
      "D2": -0.06958512216806412,
      "PPE": -0.14074255526065826
    },
    "clinical_prompt": "Analyze the following Parkinson's Disease voice biomarker assessment:\n\nPATIENT ID: patient_38\nPREDICTION: Healthy\nCONFIDENCE: 99.9%\n\nTOP CONTRIBUTING FEATURES:\n\n1. spread2 (spread2)\n   Patient Value: -2.0395\n   Normal Range: Not specified\n   SHAP Impact: -0.2399 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n2. spread1 (spread1)\n   Patient Value: -1.6662\n   Normal Range: Not specified\n   SHAP Impact: -0.1586 (\u2193 decreases PD probability)\n   Clinical Significance: Clinical interpretation not available\n\n3. Pitch Period Entropy (PPE)\n   Patient Value: -1.4793\n   Normal Range: 0.1-0.3\n   SHAP Impact: -0.1407 (\u2193 decreases PD probability)\n   Clinical Significance: Increased entropy indicates irregular vocal fold vibration\n\n4. Recurrence Period Density Entropy (RPDE)\n   Patient Value: -2.1383\n   Normal Range: 0.4-0.7\n   SHAP Impact: 0.1258 (\u2191 increases PD probability)\n   Clinical Significance: Altered RPDE reflects changes in vocal signal complexity\n\n5. Fundamental Frequency (MDVP:Fo(Hz))\n   Patient Value: 1.8209\n   Normal Range: 85-180 Hz (male), 165-255 Hz (female)\n   SHAP Impact: -0.0968 (\u2193 decreases PD probability)\n   Clinical Significance: Reduced variability indicates vocal rigidity\n\nTASK: Based on the SHAP analysis above, provide a clinical interpretation that:\n1. Summarizes the key acoustic findings in 2-3 sentences\n2. Explains what the top features indicate about vocal function\n3. Relates findings to PD motor symptoms (rigidity, bradykinesia, tremor)\n4. Assesses the reliability of this prediction based on feature patterns\n\nKeep the explanation concise and accessible to healthcare providers.\n"
  }
]